[go: up one dir, main page]

CN1215755A - 将预定改变引入有核细胞基因组的靶序列中的方法 - Google Patents

将预定改变引入有核细胞基因组的靶序列中的方法 Download PDF

Info

Publication number
CN1215755A
CN1215755A CN98118786A CN98118786A CN1215755A CN 1215755 A CN1215755 A CN 1215755A CN 98118786 A CN98118786 A CN 98118786A CN 98118786 A CN98118786 A CN 98118786A CN 1215755 A CN1215755 A CN 1215755A
Authority
CN
China
Prior art keywords
cell
chimeric
chimeric vector
target sequence
vector
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN98118786A
Other languages
English (en)
Other versions
CN1117866C (zh
Inventor
E·B·克米克
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Thomas Jefferson University
Original Assignee
Thomas Jefferson University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomas Jefferson University filed Critical Thomas Jefferson University
Publication of CN1215755A publication Critical patent/CN1215755A/zh
Application granted granted Critical
Publication of CN1117866C publication Critical patent/CN1117866C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/02—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Mycology (AREA)
  • Environmental Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)

Abstract

本发明涉及多核苷酸,它的第一链含有核糖核苷酸和脱氧核糖核苷酸两种,而第二链仅含有脱氧核糖核苷酸;其中链是沃森－克里克规则配对的并且通过寡核苷酸连接,如此该多核苷酸至多具有一个单一3′末端和一个单一5′末端。可将这些末端连接,这样多核苷酸就成为一个单一连续环状聚合物(single continuous circular polymer)。该多核苷酸可用于向靶基因中引入特定改变。

Description

将预定改变引入有核细胞基因组的靶序列中的方法
本申请是申请号为94194935.4，申请日为1994年12月9日，发明名称为“用于真核细胞中定点突变的化合物”的发明专利申请的分案申请。
本申请是于1993年12月9日递交的第08/164303号专利申请的后续申请，后者全文引入本文以供参考。
1．发明领域
本发明涉及分子遗传学领域。具体地说它涉及向活的、培养的真核细胞中引入特定基因改变的核酸化合物及其应用。更具体地说，它主要涉及基本上沃森-克里克规则配对的双链核酸，其中双链中的一条链的部分包含含2′-O或2′-OMe核糖的核苷酸，剩余部分包含脱氧核糖核苷酸。
2．发明背景
2.1．嵌合和/或杂种双链核酸
本发明领域涉及核酸。核酸是杂聚物，即不同亚单位的聚合物，亚单位是通过定向的磷酸二酯键或其衍生物连接形成聚合物。双链核酸是这样的核酸，按照尿嘧啶或胸腺嘧啶与腺嘌呤对应和胞嘧啶与鸟嘌呤对应的原则，双链中第一链的每一碱基对应于第二链的碱基。据说拥有这种对应性的逆平行双链是沃森-克里克规则配对的。双链核酸可有两种主要类型：核糖核酸和脱氧核糖核酸。每种核糖核苷酸都有相应的脱氧核糖核苷酸，例如，腺嘌呤和脱氧腺嘌呤，胞嘧啶和脱氧胞嘧啶，鸟嘌呤和脱氧鸟嘌呤，尿嘧啶和胸腺嘧啶。如本领域中所用的那样，在同一链中存在核糖核苷酸和脱氧核糖核苷酸的核酸被称为混合或嵌合(下文称“嵌合”)核酸。其中脱氧核糖核苷酸和核糖核苷酸相互对应的双链核酸被称为杂种双链(hybrid-duplex)。当两条链形成少于其全部碱基的双链核酸区时，所形成的分子被称为异形双链(heteroduplex)。
更经常地，双链核酸的两条链是非共价键合的，而仅通过沃森-克里克规则配对相连。然而，双链的两条链可通过寡核苷酸连接形成单一聚合物(single polymer)。连接寡核苷酸不是沃森-克里克规则配对的。其中第一链和第二链是单一聚合物的部分的异形双链被称为“发夹双链”或“柱和环”结构。本文采用前一种名称。
本文所用嵌合现象是核酸聚合物的一种特性，而杂种现象则是双链的一种特性。例如，mRNA及其模板形成杂种双链，但二者都是非嵌合的，然而例如嵌合的八核苷酸5′d(TTTT)-r(CCCC)3′和5′r(GGGG)-d(AAAA)3′相互形成沃森-克里克规则双链，但生成的双链是非杂种双链。下文称非杂种双链的双链核酸为“同质双链”(homo-duplex)。除非另外特别说明，同质双链仅指包含脱氧核苷酸的双链。最后，值得注意的是本领域中称沃森-克里克规则双链的形成为“杂交(hybridigation)”，即使其形成的是非杂种双链核酸。
对X射线衍射和二维NMR分析嵌合和/或杂种核酸结构的研究感兴趣的人们已合成了用于此研究的嵌合核酸和杂种双链核酸。参见，例如Salazar,M。等，1994,J.Mol.Biol.241:440-55和Egli,M.等，1993,Biochemistry 32:3221-37(r3d7.d10形式的双链的嵌合杂种双链)；Ban,C.等，1994,J.Mol.Biol.236:275-85(d5r1d4形式的自身互补嵌合杂种双链)；Chou,S.H.,1991,Biochemistry 30:5248-57(d4r4d4形式的自身互补和非自身互补的嵌合杂种双链)。这些双链核酸的互补链彼此是非共价键合的；它们仅通过沃森-克里克规则配对相连。
合成了嵌合核酸的第二组科学家感兴趣于核糖酶(ribozyme)的研究和用途，核糖酶即自身切开或切开其它RNA的RNA分子。Perreault,J.P.等，1990,Nature 344:565；Taylor,N.R.等，1992,Neucleic Acids Research20:4559-65；Shimaya,T.,1993,Nrucleic Acids Research 21:2605。这些研究发现嵌合核糖酶具有活性，并且对核酸酶的消化比RNA核糖酶具有更强的耐受性。嵌合核糖酶是自身互补的，即沃森-克里克规则配对链是共价连接的。在嵌合核糖酶的研究期间合成的化合物不同于上面提到的杂种双链分子，它们被合成用于结构的研究，因为其中的嵌合核糖酶不包括稳定的杂种双链。因而，具有DNA结合臂的嵌合核糖酶与其底物结合，并形成杂种双链。Yang,G.H.等，1990,Biochemistry 29:11156-60。还参见Sawata,S.等，1993,Neucleic Acids Research 21:5656-60；Hendry,P等，1992,Neucleic Acids Research 20:5737-41；Shimayama,T.,1993,Neucleic Acids Research 21:2605。核糖酶催化RNA底物的切开，杂种双链因此溶解。
2.2．真核细胞中定点遗传改变
分子生物学领域的技术人员知道不仅经常需要向靶真核细胞中引入新的多核酸序列，即新的基因，而且也需要对靶细胞中确定的预先存在的基因加以改变。靶细胞可在培养物中使用或者使用它建立转基因动物。
已经建立了许多向培养的真核细胞中引入DNA的技术。这些技术包括磷酸钙沉淀法，DEAE-葡聚糖介导的胞吞作用，电穿孔，脂质体介导的融合，使用复制缺损病毒的转导作用。然而，这些技术虽然十分普遍地用于向真核细胞中引入功能性基因，但它们不能轻而易举地完成对特定存在基因的改变(突变)。引入之后，外源性DNA通过异常重组在细胞基因组中随机位点上分离，而不是通过同源重组在特定位点上分离。
迄今为止，还没有一种令人普遍满意的向高级真核细胞，即哺乳动物或鸟类细胞中引入定点或特异位点的遗传改变(诱变)的方案。虽然在真核细胞中通过引入极长(＞1kb)的核酸可获得同源重组，但这些技术需要应用复杂的筛选技术，因为在高级真核细胞中异常重组率大大超过了同源重组率。Thomas,K.R.&Smithies,M.R.,1987,Cell 52:503。还参见Valancius,V.&Smithies,O.,1991,Mol.Cell.Biol.11:4389(比较真核细胞中线性化和超螺旋质粒的同源重组)。
一种完成优势定点诱变的方法是向细胞中直接引入单链寡脱氧核苷酸。这一技术被成功地用于酵母中，同源重组在啤酒酵母(Saccharomycescerevisiae)中的活性显著高于真核细胞。Moreschell,R.P.等，1988,Proc.Natl.Acad.Sci.85:524-28；Yamamoto,T.等，1992,Yeast 8:935-48并且，至今也没有用单链寡核苷酸成功地转化哺乳动物或鸟类细胞的报道。研究表明改变的嘌呤和嘧啶碱基区，即〔d(TG)30·d(AC)30〕显示显示了令人喜悦的重组率，由此可推知哺乳动物中靶DNA结构和同源重组率之间的关系。对培养的哺乳动物细胞的非复制质粒的研究证实了这些效果。Wahls,W.P.等，1990,Mol.Cell.Biol.10:785-93。这些实验没有进而表明外源性核酸和细胞基因组之间的重组。
曾尝试使用RecA，一种促进细菌(大肠杆菌)中同源重组的蛋白质来促进真核细胞中的同源重组。但是，这些尝试显然未获得成功。例如，W.Bertling的美国专利4950599公开了在真核细胞中使用RecA导致极低的定向位点突变率，并且同源重组率也未增高。D.Zarling和E.Sane的专利申请WO93/22443及D.C.Gruenert和Z.Kunzelmann的申请94/04032都旨在校正培养的涉及囊纤维变性的细胞系中的基因缺损。这些出版物公开了证实原理的原始实验数据而非涉及操作方法实施例的数据。为将多核苷酸/RecA复合物引入到核中，Zarling和Gruenert使用膜是通透性的细胞，尽管这类细胞不能进一步生长。另外，即使这些出版物宣称在完整细胞中发生了RecA促进同源重组，它们也未给出对其频率的定量评价。因此，还没有证据可令人信服地表明在任何活的真核细胞中，使用原核RecA导致的同源重组率明显高于自发性同源重组率。
3．发明概述
本发明涉及单一共价连接的双链寡核苷酸，它与所研究的基因同源，且具有脱氧核糖核苷酸和核糖核苷酸。为了产生遗传改变，在同源区内，有一对或多对非对应(下文称“异源”或“突变基因”)碱基对。通常，细胞原有的同源重组过程导致突变基因核苷酸插入靶基因组位置。可使用本发明的双链寡核苷酸(下文称“嵌合载体”)向基因中引入异源碱基对，特定地改变所研究的基因。异源碱基对可能是不同于所研究的基因的碱基对，或者可能是所研究基因中存在的碱基对之外那些碱基对(插入)，或者异源碱基对还可能是不存在于所研究基因中的碱基对(缺失)。本发明部分地是基于下述发现，即载体中包含杂种双链核酸的约15-50个碱基对区大大提高所研究基因的改变率。当异源碱基对区是1-50个碱基对时，异源碱基对可以同质或杂种双链存在于本发明的载体中。当异源碱基对长度大于50个碱基对时，它优选以同质双链存在。
可采用任何已知的向真核细胞中引入核酸的方法向靶细胞中引入载体。虽然就理论而言没有限定，但据信嵌合载体是通过靶细胞的重组/修复机制来参与的，并且经基因转化或同源重组指导靶基因改变。
4．附图的简要说明
图1显示图表表示的两种嵌合载体。特定标记如下：1，第一链；2，第二链；3，异源区；4，同质区；5，连接物；6，连接位点。
图1的符号图解杂种双链(四聚物)
Figure A9811878600062
同质双链(四聚物)
Figure A9811878600063
未配对的
图1A是R-D-R形式的连接的嵌合载体。
图1B是R-D-R形式的具有单一3′和5′末端的发夹式嵌合载体。
5．发明详述
5.1．本发明嵌合载体的描述
本发明包括含有含脱氧核糖和核糖的碱基双链核酸。因此它们包括DNA和RNA区，故而被称为“嵌合载体”。嵌合载体的核糖核苷酸的2′-O可以是甲基化的。任何磷酸二酯都可被硫代磷酸二酯或甲基磷酸二酯替代。
本发明的嵌合载体是单一核酸聚合物。因此本发明的嵌合载体须至少包括1个碱基至更通常的3或4个碱基，这些碱基不是沃森-克里克规则配对的。这些未配对碱基区连接两条沃森-克里克规则配对的碱基链。与其它合成的具有未配对核苷酸的嵌合核苷酸相反嵌合载体没有酶活性，即它们不催化化学反应或者在没有生物能源，如ATP存在下它们自身进行化学反应。
优选实施方案中的连接区碱基是脱氧核糖核苷酸。可构建具有两个连接区的嵌合载体，以使聚合物的3′和5′末端与相邻的互补链核苷酸呈沃森-克里克规则配对。它们易于连接使嵌合载体形成单一连续环状核酸聚合物。
基本上，嵌合载体的所有其余碱基都是沃森-克里克规则配对的。本文所描述的碱基是沃森-克里克规则配对的或它们形成双链核酸应被理解为在适当的温度和盐的条件下，它们可形成碱基对或双链核酸。应该知道在某些少盐和/或升高的温度条件下，沃森-克里克规则碱基对会失去热力学稳定性而使得双链核酸熔解掉或变性。还应知道一或两对碱基对失配并不影响本发明的可操作性。
本发明的嵌合载体旨在将改变(突变)特定地引入靶基因。通过选择具有与靶位点序列相同(同源)序列的嵌合载体部分(下文称之为同源区)确定遗传改变位点。嵌合载体序列和靶基因之间的不同区被称为异源区。应注意到嵌合载体与靶基因虽是异源的，但在该载体区中并不是异形双链。根据本发明的优选实施方案，每个嵌合载体有两个同源区，它们位于插入的异源区侧翼，所有这三个区都以单一连续双链核酸形式存在。再有，依据本发明，每个同源区包括杂种双链核酸部分。每个杂种双链至少是4对碱基对，优选为8对碱基对，更优选为约20-30对碱基对。嵌合载体的作用并不受到杂种双链区内同质双链的二核苷酸碱基对的影响，置入嵌合载体使3′和5′末端彼此连接。两个同源区的长度至少为20对碱基对，优选在40-60对碱基对之间。
依据本发明，可将同质双链核酸区排列在载体的杂种双链/同源区之间。被插入的同质双链区可包括异源区。当异源区少于约50对碱基对，优选地少于约20对碱基对时，可存在或不存在被插入的同质双链区。当异源区超过约20对碱基对时，包含异源区的被插入同质双链是优选的。
5.2．本发明的嵌合载体的构建
可使用任意方法合成本发明的嵌合载体。使用经改进的用于DNA固相合成的技术可最简便地合成嵌合载体。参见Caruthers,M.H.,1985,Science 230:281-85；Itakura,K.等，1984,Ann.Rev.Biochem.53:523-56。可合成RNA和嵌合核酸的改进方法公开于Scaringe,S.A.等，1990,NucleicAcids Research 18:5433-41；Usman,N.等，1992,Nucleic Acids Research20:6695-99；和Swiderski,P.M.等，1994,Anal.Biochem.216:83-88，上述文献均全文引入本文以供参考。有关嵌合核酸合成的新近进展综述于Usman,N.&Cedergren,R.,1992,Trends Bioch.Sci.17:334-9。
插入两个杂种双链区之间的包含同质双链区的嵌合载体可使用半合成技术来建立。构建两种合成的具发夹构象的嵌合多聚核酸。使用与两种不同限制酶的消化产物的重叠部分互补的重叠交叉末端，构建两种嵌合核酸的游离3′和5′末端。得到与限制酶消化末端互补的同质双链区。可采用本领域技术人员熟知的技术来完成限制酶位点与克隆DNA片段末端的加成，所述技术例如，但不限于使用伸展引物的PCR扩增和包含限制位点的连接体的平整末端连接。可使用常规的酶促技术连接两种嵌合核苷酸和同质双链区。通过在Tris Borate EDTA缓冲液中的6％聚丙烯酰胺电泳从不完全反应的底物中分离两个末端连接的嵌合寡核苷酸。该线性加帽的分子是压缩的并且在这一条件下的电泳更缓慢。
仅含有天然产生的核苷酸的嵌合载体也可用于本发明。据发现包含约20个核糖核苷酸的杂种双链区的嵌合载体在体外是RNAse H抗性的。可通过用2′-O甲基化核糖核苷酸替代核糖核苷酸获得对酶促降解的抗性。另外或者可选择性地，核酸的磷酸二酯键可被硫代磷酸二酯键替代。Shimayama,T.等，1993,Nucleic Acids Research 21:2605.也可以使用含阿拉伯糖的核苷酸。本文所用术语核酸意指包括带有这些修饰的核酸。
5.3．本发明的嵌合载体的应用
本发明的嵌合载体可用于靶细胞基因组的特定位置上的突变。采用其核酸序列定义靶位的特定位置，下文中称此核酸序列为靶序。依据本发明构建嵌合载体，其中除存在某些杂种双链区外，同源区与靶序列一致。异源区编码被引入的变化。变化可是序列的一个或多个碱基变化或者是一个或多个碱基的加成。当靶序列的变化是少于约20个碱基的加成时，可采用一或二个杂种双链区实现本发明。当靶序列的变化是多于约50个碱基的加成时，则优选采用被包括在同质双链区内的异源区。
本发明的实现要求向靶细胞核中引入嵌合载体。任何导致这种引入的方法均可使用。这类方法包括电穿孔法，DEAE葡聚糖法，磷酸钙沉淀法，脂质体介导的融合法(LIPOFECTIN)和直接注射法。电穿孔法是特别适合的。
在本发明的一个实施方案中嵌合载体用于建立转基因动物。按照文献描述方法，采用直接注射法向卵细胞的原核中引入嵌合载体，所述文献是Brinster R.L.等，1989,PROC.NATL.ACAD.SCI.86:7087；还有T.E.Wagner和P.C.Hoppe的美国专利4,873,191，二者都全文引入本文以供参考。另外，可向胚胎干细胞中引入嵌合载体，可用正常胚泡细胞聚集胚胎干细胞从而产生嵌合动物，以嵌合动物的后代可重新获得转基因动物，该方法参见Capccchi,M.R.,1989,Science 244:1288，该文献全文引入本文以供参考。
采用电穿孔法，每10,000个被处理细胞就有一个细胞在靶序列上发生特异性突变(下文称“转化”)。因此，本发明的实践包括从大量未突变细胞中选择转化细胞的方法的使用。在另一个实施方案中，转化细胞的优点增多。这些增多的优点的非限制性实例包括抗药性，生长调节的改变和利用代谢物能力的改变。在另一个实施例中，选择方法是负选择法，使用该方法在所选择条件下使得被转化细胞不能生长，并且通过使其暴露在选择性破坏增殖细胞的条件下而除去未被转化的细胞。
另外，被转化的细胞可具有改变的细胞表面抗原表型，它可通过免疫荧光进行检测，采用荧光激活细胞分离器进行选择。
当向细胞中引入嵌合载体的方法是直接注射法时，例如当采用原核注射法建立转基因动物时，每10,000个细胞的转化率可高于1个细胞。因此，大大降低了选择的需要。
采用电穿孔法转化的嵌合载体的典型用量是每百万个培养细胞在10-1000ng之间。
6．实施例
6.1．实施例1：对黑粉菌属真菌的体内活性
野生型黑粉菌具有功能性的尿嘧啶(ura)-3基因，其产物是尿嘧啶生物合成途径中的一部分。当野生型黑粉菌生长于5′-fluororotic acid(5FOA)培养基中时，细胞由于该酸加入到上述途径中而死亡。假如尿嘧啶-3发生突变，则不会产生尿嘧啶-3 mRNA，细胞就得以在5FOA培养基中存活。
内源性尿嘧啶-3基因序列是本领域中已知的。在一组实验中，该序列的碱基358由腺嘌呤变为胸腺嘧啶，这一突变导致功能障碍蛋白的产生。
嵌合载体的合成如下：
碱基358突变的载体：(358 RNA载体)5′TGCCGATCGGCAACTTTTGUUGCCGAUCGGCAAATTT3′(SEQ ID:1)
该358载体采用发夹构象。划线碱基表示核糖核酸残基。黑体字母表示突变基因(异型区)。斜体“T”表示未配对碱基。
建立具有相同序列但不包含核糖核酸的载体作为对照。在该载体中胸腺嘧啶被尿嘧啶替代。
对照载体在碱基358进行突变：(DNA 358载体)5′TGCCGATCGGCAACTTTTGTTGCCGATCGGCAAATTT  3′
(SEQ ID:2)也采用发夹构象。再者，黑体残基是突变基因。
进行体内转化实验，按照本领域所熟知的方法，将U.maydis细胞制成回收率为50ul转化缓冲液中106个细胞的原生质体，并使用不同量的嵌合载体进行转染或者将同源(仅DNA)载体与原生质体在37℃混合。然后，将细胞铺于所选择的培养基上，计数存活菌落(转化细胞)的数目。结果以下面的表格形式表示：
    转染数量(ug)     载体-358类型     存活菌落数
    0.1     DNA     0
    0.1     嵌合的     13
    0.25     DNA     1
    0.25     嵌合的     49
    0.75     DNA     12
    0.75     嵌合的     131
    1.0     DNA     19
    1.0     嵌合的     573
这些数据表明使用RNA 358载体的细胞转染与使用相应DNA载体的转染相比，极大地提高了细胞的存活率。
6.2．实施例2:NIH 3T3细胞的转化
NIH 3T3细胞是具有良性(可控制的)生长特性的人细胞。恶性(无控制的)生长特性是由致癌基因H→ras中的单位点突变给予的，所谓突变是由Thr替代Gly12。这样，G→T12导致生长特性的易于选择的变化。Taparowsky,E.等，1982,Nature 300:762；Sukumar S.等，1983,Nature306:658。
建立下述序列以指导发生G→T12突变的嵌合载体：5′-CACACCGACGGCGCCCACCACTTTGTGGTGGGCGCCGTCGGTGTGGGTTTGCC-3′(SEQ ID:3)
该序列以常规单字母代码表示，其它特点是未划线的表示RNA，未配对碱基是斜体，突变体碱基是黑体。需要注意的是，环化之后通过两个三胸腺嘧啶序列将嵌合载体分为两条基本上互补的链，并且所有含核糖的核苷酸仅存在于两条链中的一条。
使用2′-OMe核糖碱基合成两种形式的嵌合载体，它们分别具有一个(“R”)和两个(“R-D-R”)的翼侧有四个脱氧核糖残基的杂种双链区。R-D-R形式如上SEQ ID:3所示，R形式除碱基6-9是脱氧核苷酸外是相同的。值得注意的是，5′和3′末端是脱氧核苷酸。采用如在重组DNA中常用的相同DNA连接酶法，在合成之后环化嵌合载体。连接之后，通过两次重复的制备性D600凝胶(AT Biochem,Malvern,PA)电泳从底物中分离环化嵌合载体。
对照载体是：1)没有杂种双链的相同序列(“同质双链”
所示数据)；2)具有5′-GCCCACACCGACGGCGCCACCAC-3′(SEQ ID 4)序列的未配对DNA(“sDNA”所示数据)；3)没有异源区的嵌合载体，因而是没有突变基因的核苷酸(未显示数据)。
采用电穿孔法通过转化NIH 3T3细胞(1×106个细胞)进行实验。电穿孔法之后，将细胞以4×103个接种密度铺于培养基中并使其生长14天。用结晶紫染色灶形成细胞使转化细胞可见。使用编码T12形式的H ras的质粒pT24作为阳性对照。该对照用于测定转染的NIH 3T3细胞中的异常重组水平。该实验重复5次，下表表示其概括性结果。除下面所示结果外，使用没有突变基因密码子的嵌合载体的对照实验未显示出NIH 3T3细胞转化灶。
    载体类型     转染量(每106个细胞)     转化细胞每106个细胞(14天)
pT24(阳性对照)     10ug     57
sDNA     1ug     2
sDNA     10ug     13
同质双链     1ug     0
同质双链     10ug     2
嵌合的     50ng     R-D-R    R19       12
嵌合的     200ng     55       43
嵌合的     1ug     139      103
这些结果表明嵌合载体通过同源重组引入特定突变以转化哺乳动物细胞。该实验中的转化率大大高于通过异常重组的转化率，这是由使用包含完全突变的H-ras基因的pT24阳性对照载体进行转染观察到的。因此，在哺乳动物细胞中使用嵌合载体的同源重组率远远高于异常重组率。
序列表
(1)普通信息：
 (ⅰ)申请者：Kmiec,Eric
 (ⅱ)发明题目：用于真核细胞中定点突变的化合物和方法
 (ⅲ)序列数：4
 (ⅳ)通讯地址：
 (A)收信人：Pennie & Edmonds
 (B)街道：1155 Avenue ofthe Americas
 (C)城市：New York
 (D)国家：NY
 (F)邮政编码：10036-2731
 (ⅴ)可读计算机源：
 (A)媒介类型：软盘
 (B)计算机：IBM PC兼容机
 (C)操作系统：PC-DOS/MS-DOS
 (D)软件：PatentIn Release #1.0,Version#1.25
 (ⅵ)当前申请资料：
 (A)申请号：US
 (B)递交日：
 (C)分类：
 (ⅷ)律师/代理人信息：
 (A)姓名：Friebel,Thomas E.
 (B)注册号：29,258
 (C)文献/摘要号：7991-009
 (ⅸ)通讯信息：
 (A)电话：(212)790-9090
 (B)传真：(212)869-8864/009
(2)第一序列(SEQ ID:1)信息：
 (ⅰ)序列特征：
 (A)长度：37对碱基对
 (B)类型：核酸
 (C)链合方式：自身互补
 (D)拓扑结构：线性
 (ⅱ)分子类型：DNA/RNA
 (ⅸ)特点：
 (A)名称/检索表：-
 (B)位点：19..32
 (D)其它信息：/标记=a/注=“RNA”
 (ⅹⅰ)序列描述：第一序列描述：TGCCGATCGG CAACTTTTGU UGCCGAUCGG CAAATTT    37
(2)第二序列(SEQ ID:2)信息：
 (ⅰ)序列特征：
 (A)长度：37对碱基对
 (B)类型：核酸
 (C)链合方式：自身互补
 (D)拓扑结构：线性
 (ⅱ)分子类型：DNA
 (ⅹⅰ)序列描述：第三序列描述：TGCCGATCGG CAACTTTTGT TGCCGATCGG CAAATTT    37
(2)第三序列(SEQ ID:3)信息：
 (ⅰ)序列特征：
 (A)长度：53对碱基对
 (B)类型：核酸
 (C)链合方式：自身互补
 (D)拓扑结构：线性
 (ⅱ)分子类型：DNA/RNA
 (ⅸ)特点：
 (A)名称/检索表：-
 (B)位点：2..5
 (D)其它信息：/标记=b/注=“RNA”
 (ⅸ)特点：
 (A)名称/检索表：
 (B)位点：10..21
 (D)其它信息：/标记=d/注=“RNA”
(ⅸ)特点：
 (A)名称/检索表：
 (B)位点：51..52
 (D)其它信息：/标记=f/注=“RNA”
 (ⅹⅰ)序列描述：第三序列描述：CACACCGACG GCGCCCACCA CTTTGTGGTG GGCGCCGTCG GTGTGGGTTT GCC    53
(2)第四序列(SEQ ID:4)信息：
 (ⅰ)序列特征：
 (A)长度：23对碱基对
 (B)类型：核酸
 (C)链合方式：自身互补
 (D)拓扑结构：线性
 (ⅱ)分子类型：DNA
 (ⅹⅰ)序列描述：第四序列描述：GCCCCACCG ACGGCGCCAC CAC    23

Claims (6)

1．一种将预定改变引入有核细胞基因组的靶序列中的方法，它包括下述步骤：
a．提供一种嵌合载体，它具有两个靶序列同源区，和一个排列在两个同源区之间的编码这种改变的异源区；
b．使嵌合载体保持在细胞核中，以使嵌合载体与靶序列发生遗传学重组。
2．权利要求1的方法，其中核是卵的原核并且采用直接注射法引入改变。
3．权利要求1的方法，其中核是胚胎干细胞核并且采用直接注射法引入改变。
4．一种获得改变特征的细胞群的方法，它包括下述步骤：
a．提供一种嵌合载体，它具有两个靶序列同源区，和一个排列在两个同源区之间的编码这种改变的异源区；
b．使嵌合载体保持在细胞核中，由此嵌合载体与靶序列发生重组，细胞被转化；及
c．选择转化细胞。
5．权利要求4的方法，其中细胞是哺乳动物细胞。
6．权利要求4的方法，其中细胞是酵母菌或真菌。
CN98118786A 1993-12-09 1998-08-22 将预定改变引入有核细胞基因组的靶序列中的方法 Expired - Fee Related CN1117866C (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16430393A 1993-12-09 1993-12-09
US164303 1993-12-09
US164,303 1993-12-09

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN94194935A Division CN1048254C (zh) 1993-12-09 1994-12-09 用于将预定的改变引入靶基因中的化合物

Publications (2)

Publication Number Publication Date
CN1215755A true CN1215755A (zh) 1999-05-05
CN1117866C CN1117866C (zh) 2003-08-13

Family

ID=22593886

Family Applications (2)

Application Number Title Priority Date Filing Date
CN94194935A Expired - Fee Related CN1048254C (zh) 1993-12-09 1994-12-09 用于将预定的改变引入靶基因中的化合物
CN98118786A Expired - Fee Related CN1117866C (zh) 1993-12-09 1998-08-22 将预定改变引入有核细胞基因组的靶序列中的方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CN94194935A Expired - Fee Related CN1048254C (zh) 1993-12-09 1994-12-09 用于将预定的改变引入靶基因中的化合物

Country Status (15)

Country Link
US (3) US5565350A (zh)
EP (1) EP0733059B1 (zh)
JP (1) JP3585238B2 (zh)
KR (1) KR100386337B1 (zh)
CN (2) CN1048254C (zh)
AT (1) ATE196311T1 (zh)
AU (1) AU691550B2 (zh)
CA (1) CA2178729A1 (zh)
DE (2) DE733059T1 (zh)
DK (1) DK0733059T3 (zh)
ES (1) ES2149962T3 (zh)
GR (1) GR3034988T3 (zh)
NZ (1) NZ278490A (zh)
PT (1) PT733059E (zh)
WO (1) WO1995015972A1 (zh)

Families Citing this family (812)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6475795B1 (en) * 1991-07-03 2002-11-05 Meditech Research, Ltd. Use of hyaluronan in gene therapy
US6335434B1 (en) 1998-06-16 2002-01-01 Isis Pharmaceuticals, Inc., Nucleosidic and non-nucleosidic folate conjugates
US8153602B1 (en) 1991-11-19 2012-04-10 Isis Pharmaceuticals, Inc. Composition and methods for the pulmonary delivery of nucleic acids
US20020108136A1 (en) * 1997-03-21 2002-08-08 Sri Transgenic animals produced by homologous sequence targeting
US5523389A (en) * 1992-09-29 1996-06-04 Isis Pharmaceuticals, Inc. Inhibitors of human immunodeficiency virus
CA2170869C (en) 1993-09-03 1999-09-14 Phillip Dan Cook Amine-derivatized nucleosides and oligonucleosides
US6420549B1 (en) 1995-06-06 2002-07-16 Isis Pharmaceuticals, Inc. Oligonucleotide analogs having modified dimers
US5760012A (en) * 1996-05-01 1998-06-02 Thomas Jefferson University Methods and compounds for curing diseases caused by mutations
US5731181A (en) * 1996-06-17 1998-03-24 Thomas Jefferson University Chimeric mutational vectors having non-natural nucleotides
US5898031A (en) 1996-06-06 1999-04-27 Isis Pharmaceuticals, Inc. Oligoribonucleotides for cleaving RNA
US9096636B2 (en) * 1996-06-06 2015-08-04 Isis Pharmaceuticals, Inc. Chimeric oligomeric compounds and their use in gene modulation
US7812149B2 (en) 1996-06-06 2010-10-12 Isis Pharmaceuticals, Inc. 2′-Fluoro substituted oligomeric compounds and compositions for use in gene modulations
US20030044941A1 (en) 1996-06-06 2003-03-06 Crooke Stanley T. Human RNase III and compositions and uses thereof
EP0931090B1 (en) * 1997-03-03 2004-04-21 Applera Corporation Improved chimeric oligonucleotide vectors
US5948653A (en) * 1997-03-21 1999-09-07 Pati; Sushma Sequence alterations using homologous recombination
US6524613B1 (en) 1997-04-30 2003-02-25 Regents Of The University Of Minnesota Hepatocellular chimeraplasty
GB9711015D0 (en) * 1997-05-28 1997-07-23 Zeneca Ltd Improvements in or relating to organic compounds
US6887906B1 (en) 1997-07-01 2005-05-03 Isispharmaceuticals, Inc. Compositions and methods for the delivery of oligonucleotides via the alimentary canal
US7094606B2 (en) 1997-08-05 2006-08-22 Arntzen Charles J Use of mixed duplex oligonucleotides to effect localized genetic changes in plants
US7102055B1 (en) 1997-11-18 2006-09-05 Pioneer Hi-Bred International, Inc. Compositions and methods for the targeted insertion of a nucleotide sequence of interest into the genome of a plant
WO1999025853A1 (en) * 1997-11-18 1999-05-27 Pioneer Hi-Bred International, Inc. Targeted manipulation of herbicide-resistance genes in plants
AU760113C (en) * 1997-11-18 2004-04-22 Pioneer Hi-Bred International, Inc. Compositions and methods for genetic modification of plants
EP0945507A1 (de) * 1998-03-27 1999-09-29 Boehringer Mannheim Gmbh Tumorspezifische Expressionskontrollregion und deren Verwendung
US20040186071A1 (en) 1998-04-13 2004-09-23 Bennett C. Frank Antisense modulation of CD40 expression
US6004804A (en) 1998-05-12 1999-12-21 Kimeragen, Inc. Non-chimeric mutational vectors
US6010907A (en) 1998-05-12 2000-01-04 Kimeragen, Inc. Eukaryotic use of non-chimeric mutational vectors
CA2329252A1 (en) 1998-05-21 1999-11-25 Isis Pharmaceuticals Inc. Compositions and methods for topical delivery of oligonucleotides
CA2329130A1 (en) * 1998-05-21 1999-11-25 Isis Pharmaceuticals Inc. Compositions and methods for non-parenteral delivery of oligonucleotides
US6693185B2 (en) 1998-07-17 2004-02-17 Bayer Bioscience N.V. Methods and means to modulate programmed cell death in eukaryotic cells
DE19836098A1 (de) 1998-07-31 2000-02-03 Hoechst Schering Agrevo Gmbh Pflanzen, die eine modifizierte Stärke synthetisieren, Verfahren zur Herstellung der Pflanzen, ihre Verwendung sowie die modifizierte Stärke
BR9914465A (pt) 1998-09-29 2001-10-09 Gamida Cell Ltd Métodos para controlar a proliferação e a diferenciação de células-tronco e células progenitoras e uma composição farmacêutica para induzir a diferenciação em uma população de células
US6077709A (en) 1998-09-29 2000-06-20 Isis Pharmaceuticals Inc. Antisense modulation of Survivin expression
AU773808B2 (en) 1998-11-09 2004-06-10 Bayer Cropscience Aktiengesellschaft Nucleic acid molecules from rice and their use for the production of modified starch
US6438561B1 (en) * 1998-11-19 2002-08-20 Navigation Technologies Corp. Method and system for using real-time traffic broadcasts with navigation systems
EP1151409A1 (en) * 1999-01-18 2001-11-07 Maxygen, Inc. Methods of populating data stuctures for use in evolutionary simulations
US6917882B2 (en) 1999-01-19 2005-07-12 Maxygen, Inc. Methods for making character strings, polynucleotides and polypeptides having desired characteristics
US6376246B1 (en) 1999-02-05 2002-04-23 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
US20030054390A1 (en) * 1999-01-19 2003-03-20 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
US6368861B1 (en) 1999-01-19 2002-04-09 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
DE60044223D1 (de) 1999-01-19 2010-06-02 Maxygen Inc Durch oligonukleotide-vermittelte nukleinsäuren-rekombination
US20070065838A1 (en) * 1999-01-19 2007-03-22 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
US6961664B2 (en) 1999-01-19 2005-11-01 Maxygen Methods of populating data structures for use in evolutionary simulations
US7024312B1 (en) 1999-01-19 2006-04-04 Maxygen, Inc. Methods for making character strings, polynucleotides and polypeptides having desired characteristics
US6127124A (en) * 1999-01-20 2000-10-03 Isis Pharmaceuticals, Inc. Fluorescence based nuclease assay
US7098192B2 (en) 1999-04-08 2006-08-29 Isis Pharmaceuticals, Inc. Antisense oligonucleotide modulation of STAT3 expression
WO2000061184A2 (en) * 1999-04-08 2000-10-19 Glenn Gregory M Dry formulation for transcutaneous immunization
EP2055779A3 (en) 1999-05-07 2009-08-12 E.I. Dupont De Nemours And Company Auxin transport proteins
US6656730B1 (en) 1999-06-15 2003-12-02 Isis Pharmaceuticals, Inc. Oligonucleotides conjugated to protein-binding drugs
US6271360B1 (en) 1999-08-27 2001-08-07 Valigen (Us), Inc. Single-stranded oligodeoxynucleotide mutational vectors
WO2001025460A2 (en) * 1999-10-07 2001-04-12 Valigen, Inc. Compositions and methods for plant genetic modification
AR025996A1 (es) 1999-10-07 2002-12-26 Valigen Us Inc Plantas no transgenicas resistentes a los herbicidas.
US7430477B2 (en) * 1999-10-12 2008-09-30 Maxygen, Inc. Methods of populating data structures for use in evolutionary simulations
US7332275B2 (en) 1999-10-13 2008-02-19 Sequenom, Inc. Methods for detecting methylated nucleotides
WO2001035735A1 (en) * 1999-11-19 2001-05-25 Hematech, Llc Production of ungulates, preferably bovines that produce human immunoglobulins
US7253334B2 (en) * 2000-12-22 2007-08-07 Aurox, Llc Methods for cloning non-human mammals using reprogrammed donor chromatin or donor cells
US7074983B2 (en) * 1999-11-19 2006-07-11 Kirin Beer Kabushiki Kaisha Transgenic bovine comprising human immunoglobulin loci and producing human immunoglobulin
US7820878B2 (en) * 1999-11-19 2010-10-26 Kyowa Hakko Kirin Co., Ltd. Production of ungulates, preferably bovines that produce human immunoglobulins
US7414170B2 (en) * 1999-11-19 2008-08-19 Kirin Beer Kabushiki Kaisha Transgenic bovines capable of human antibody production
US6261840B1 (en) 2000-01-18 2001-07-17 Isis Pharmaceuticals, Inc. Antisense modulation of PTP1B expression
US20020055479A1 (en) 2000-01-18 2002-05-09 Cowsert Lex M. Antisense modulation of PTP1B expression
US6897020B2 (en) * 2000-03-20 2005-05-24 Newlink Genetics Inc. Methods and compositions for elucidating relative protein expression levels in cells
US20060134629A1 (en) * 2000-03-20 2006-06-22 Link Charles J Methods and compositions for elucidating protein expression profiles in cells
US6936467B2 (en) 2000-03-27 2005-08-30 University Of Delaware Targeted chromosomal genomic alterations with modified single stranded oligonucleotides
AU4948801A (en) * 2000-03-27 2001-10-08 Univ Delaware Targeted chromosomal genomic alterations with modified single stranded oligonucleotides
CA2409172A1 (en) * 2000-05-17 2001-11-22 University Of Delaware Plant gene targeting using oligonucleotides
US6686188B2 (en) 2000-05-26 2004-02-03 Amersham Plc Polynucleotide encoding a human myosin-like polypeptide expressed predominantly in heart and muscle
US6656700B2 (en) 2000-05-26 2003-12-02 Amersham Plc Isoforms of human pregnancy-associated protein-E
WO2001094610A2 (en) * 2000-06-05 2001-12-13 Thomas Jefferson University Binary hybrid mutational vectors
US7468475B2 (en) 2000-06-16 2008-12-23 Schmuelling Thomas Method for modifying plant morphology, biochemistry and physiology
US6958214B2 (en) 2000-07-10 2005-10-25 Sequenom, Inc. Polymorphic kinase anchor proteins and nucleic acids encoding the same
AU2001279069A1 (en) * 2000-07-27 2002-02-13 University Of Delaware Methods for enhancing targeted gene alteration using oligonucleotides
US6875907B2 (en) 2000-09-13 2005-04-05 Pioneer Hi-Bred International, Inc. Antimicrobial peptides and methods of use
WO2002026967A2 (en) * 2000-09-25 2002-04-04 Thomas Jefferson University Targeted gene correction by single-stranded oligodeoxynucleotides
US20020123474A1 (en) * 2000-10-04 2002-09-05 Shannon Mark E. Human GTP-Rho binding protein2
US7560622B2 (en) 2000-10-06 2009-07-14 Pioneer Hi-Bred International, Inc. Methods and compositions relating to the generation of partially transgenic organisms
US20020142397A1 (en) * 2000-12-22 2002-10-03 Philippe Collas Methods for altering cell fate
US7491534B2 (en) 2000-12-22 2009-02-17 Kirin Holdings Kabushiki Kaisha Methods for altering cell fate to generate T-cells specific for an antigen of interest
WO2002059337A1 (en) * 2001-01-26 2002-08-01 Georgetown University School Of Medicine Anti-apoptopic gene scc-s2 and diagnostic and therapeutic uses thereof
AU2002303176A1 (en) * 2001-03-27 2002-10-15 University Of Delaware Genomics applications for modified oligonucleotides
WO2002081640A2 (en) * 2001-04-06 2002-10-17 Georgetown University Gene shinc-1 and diagnostic and therapeutic uses thereof
WO2002081642A2 (en) 2001-04-06 2002-10-17 Georgetown University Gene brcc-3 and diagnostic and therapeutic uses thereof
AU2002305151A1 (en) * 2001-04-06 2002-10-21 Georgetown University Gene scc-112 and diagnostic and therapeutic uses thereof
AU2002303261A1 (en) * 2001-04-06 2002-10-21 Georgetown University Gene brcc2 and diagnostic and therapeutic uses thereof
US20030045830A1 (en) * 2001-04-17 2003-03-06 De Bizemont Therese Gene therapy with chimeric oligonucleotides delivered by a method comprising a step of iontophoresis
US20040063922A1 (en) * 2001-04-17 2004-04-01 Conrad Charles A. Methods and compositions for catalytic DNA exchange in a sequence specific manner
US7053195B1 (en) * 2001-06-12 2006-05-30 Syngenta Participatious Ag Locked nucleic acid containing heteropolymers and related methods
DK2000545T3 (da) 2001-06-20 2011-11-28 Genentech Inc Sammensætninger og fremgangsmåder til diagnose og behandling af lunge-tumor
US7803915B2 (en) 2001-06-20 2010-09-28 Genentech, Inc. Antibody compositions for the diagnosis and treatment of tumor
AU2002315393A1 (en) 2001-06-21 2003-01-08 Isis Pharmaceuticals, Inc. Antisense modulation of superoxide dismutase 1, soluble expression
EP1925672A1 (en) 2001-06-22 2008-05-28 Syngeta Participations AG Abiotic stress responsive polynucleotides and polypeptides
US6964950B2 (en) 2001-07-25 2005-11-15 Isis Pharmaceuticals, Inc. Antisense modulation of C-reactive protein expression
US7425545B2 (en) 2001-07-25 2008-09-16 Isis Pharmaceuticals, Inc. Modulation of C-reactive protein expression
US20030096772A1 (en) 2001-07-30 2003-05-22 Crooke Rosanne M. Antisense modulation of acyl CoA cholesterol acyltransferase-2 expression
US7407943B2 (en) 2001-08-01 2008-08-05 Isis Pharmaceuticals, Inc. Antisense modulation of apolipoprotein B expression
US7227014B2 (en) 2001-08-07 2007-06-05 Isis Pharmaceuticals, Inc. Antisense modulation of apolipoprotein (a) expression
US20030109476A1 (en) * 2001-08-07 2003-06-12 Kmiec Eric B. Compositions and methods for the prevention and treatment of Huntington's disease
US20030084473A1 (en) * 2001-08-09 2003-05-01 Valigen Non-transgenic herbicide resistant plants
US7456335B2 (en) * 2001-09-03 2008-11-25 Basf Plant Science Gmbh Nucleic acid sequences and their use in methods for achieving pathogen resistance in plants
EP2284195A1 (en) 2001-09-18 2011-02-16 Carnegie Institution Of Washington Fusion proteins useful for detecting analytes
EP2151244A1 (en) 2001-09-18 2010-02-10 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
US7112405B2 (en) * 2001-09-27 2006-09-26 University Of Delaware Compositions and methods for enhancing oligonucleotide-mediated gene alteration
US7468244B2 (en) * 2001-09-27 2008-12-23 University Of Delaware Polymorphism detection and separation
US20030207327A1 (en) * 2001-09-27 2003-11-06 Kmiec Eric B. Coisogenic eukaryotic cell collections
EP1961293A3 (en) 2001-09-27 2009-01-28 Pioneer Hi-Bred International, Inc. Phytate polynucleotides and methods of use
NZ566396A (en) 2001-10-09 2009-07-31 Isis Pharmaceuticals Inc Antisense modulation of insulin-like growth factor binding protein 5 expressions
US6750019B2 (en) 2001-10-09 2004-06-15 Isis Pharmaceuticals, Inc. Antisense modulation of insulin-like growth factor binding protein 5 expression
US20030228319A1 (en) 2002-04-16 2003-12-11 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
US6965025B2 (en) 2001-12-10 2005-11-15 Isis Pharmaceuticals, Inc. Antisense modulation of connective tissue growth factor expression
JP2005525095A (ja) 2002-01-02 2005-08-25 ジェネンテック・インコーポレーテッド 腫瘍の診断と治療のための組成物と方法
IL152904A0 (en) 2002-01-24 2003-06-24 Gamida Cell Ltd Utilization of retinoid and vitamin d receptor antagonists for expansion of renewable stem cell populations
EP1465982A4 (en) 2002-01-25 2006-06-07 Gamida Cell Ltd PROCESS FOR EXPANSION OF STEM AND PRESERVATIVE CELLS AND EXPANDED CELL POPULATIONS THEREWITH OBTAINED
US20060009409A1 (en) 2002-02-01 2006-01-12 Woolf Tod M Double-stranded oligonucleotides
WO2003064621A2 (en) 2002-02-01 2003-08-07 Ambion, Inc. HIGH POTENCY siRNAS FOR REDUCING THE EXPRESSION OF TARGET GENES
DE60329277D1 (de) 2002-02-01 2009-10-29 Life Technologies Corp Oligonukleotidzusammensetzungen mit verbesserter effizienz
US7135326B2 (en) * 2002-02-07 2006-11-14 E. I. Du Pont De Nemours And Company UDP-glucosyltransferases
AU2003211128A1 (en) 2002-02-20 2003-09-09 American Integrated Biologics, Inc. Transgenic production in saliva
CA2478479A1 (en) * 2002-03-07 2003-09-18 University Of Delaware Methods, compositions, and kits for enhancing oligonucleotide-mediated nucleic acid sequence alteration using compositions comprising a histone deacetylase inhibitor, lambda phagebeta protein, or hydroxyurea
MXPA04009778A (es) 2002-04-08 2004-12-13 Pionner Hi Bred International Exsercion de fibra sedosa mejorada bajo estres.
US7138512B2 (en) * 2002-04-10 2006-11-21 Georgetown University Gene SHINC-2 and diagnostic and therapeutic uses thereof
US7244565B2 (en) * 2002-04-10 2007-07-17 Georgetown University Gene shinc-3 and diagnostic and therapeutic uses thereof
AU2003228809A1 (en) 2002-05-03 2003-11-17 Sequenom, Inc. Kinase anchor protein muteins, peptides thereof, and related methods
CA2484001A1 (en) 2002-05-08 2003-11-20 Basf Plant Science Gmbh Methods for increasing oil content in plants
US20030228317A1 (en) * 2002-05-22 2003-12-11 Prafulla Gokhale Gene BRCC-1 and diagnostic and therapeutic uses thereof
US7199107B2 (en) 2002-05-23 2007-04-03 Isis Pharmaceuticals, Inc. Antisense modulation of kinesin-like 1 expression
US20030228558A1 (en) * 2002-06-11 2003-12-11 Bloom William Dennis Method of training brokers in a multi-level marketing business
WO2003106617A2 (en) * 2002-06-12 2003-12-24 Tel Aviv Medical Center Research Development Fund Oligonucleotides antibodies and kits including same for treating prostate cancer and determining predisposition thereto
WO2004026343A1 (ja) * 2002-09-20 2004-04-01 Sumitomo Phamaceuticals Co., Ltd. 部位特異的遺伝子変換促進剤および遺伝子疾患治療剤
EP2272958A1 (en) 2002-09-26 2011-01-12 ISIS Pharmaceuticals, Inc. Modulation of forkhead box O1A expression
US20040175722A1 (en) * 2002-10-07 2004-09-09 Kmiec Eric B. Methods and compositions for reducing screening in oligonucleotide-directed nucleic acid sequence alteration
US9150605B2 (en) * 2002-11-05 2015-10-06 Isis Pharmaceuticals, Inc. Compositions comprising alternating 2′-modified nucleosides for use in gene modulation
AU2003290597A1 (en) 2002-11-05 2004-06-03 Isis Pharmaceuticals, Inc. Modified oligonucleotides for use in rna interference
EP1560839A4 (en) 2002-11-05 2008-04-23 Isis Pharmaceuticals Inc CHIMERIC OLIGOMER COMPOUNDS AND THEIR USE IN GENE MODULATION
US9150606B2 (en) 2002-11-05 2015-10-06 Isis Pharmaceuticals, Inc. Compositions comprising alternating 2'-modified nucleosides for use in gene modulation
JP2006505291A (ja) * 2002-11-08 2006-02-16 ヘマテック，エルエルシー プリオンタンパク質活性が低減されたトランスジェニック有蹄動物及びその用途
ES2417879T3 (es) 2002-11-13 2013-08-09 Genzyme Corporation Modulación antisentido de la expresión de la apolipoproteína B
EP1569695B1 (en) 2002-11-13 2013-05-15 Genzyme Corporation Antisense modulation of apolipoprotein b expression
EP1572971B1 (en) 2002-11-15 2009-09-30 Morphotek Inc. Methods of generating high-production of antibodies from hybridomas created by in vitro immunization
US7144999B2 (en) 2002-11-23 2006-12-05 Isis Pharmaceuticals, Inc. Modulation of hypoxia-inducible factor 1 alpha expression
DE60323149D1 (de) 2002-12-19 2008-10-02 Bayer Cropscience Gmbh Pflanzenzellen und pflanzen, die eine stärke mit erhöhter endviskosität synthetisieren
US7468356B2 (en) 2003-02-11 2008-12-23 Antisense Therapeutics Ltd. Modulation of insulin like growth factor I receptor expression
BRPI0407514A (pt) 2003-02-17 2006-02-14 Metanomics Gmbh método para preparar um organismo não humano, polinucleotìdeo, método para preparar um vetor, vetor, célula hospedeira, polipeptìdeo, anticorpo, ácido polinucléico de anti-sentido, método para preparar uma planta, célula vegetal, tecido vegetal transgênicos, célula de um animal útil, animal útil ou um microorganismo transgênico organismo não humano, microorganismo transgênico, rendimento ou um material de propagação de uma planta ou de um animal útil, biomassa de um microorganismo, método para preparar produtos quìmicos finos, e, uso de polipeptìdeo
US7803781B2 (en) 2003-02-28 2010-09-28 Isis Pharmaceuticals, Inc. Modulation of growth hormone receptor expression and insulin-like growth factor expression
US20040185559A1 (en) 2003-03-21 2004-09-23 Isis Pharmaceuticals Inc. Modulation of diacylglycerol acyltransferase 1 expression
EP3121269A1 (de) 2003-03-31 2017-01-25 University Of Bristol Neue pflanzliche acyltransferase spezifisch für langkettige mehrfach ungesättigte fettsäuren
US20040205840A1 (en) * 2003-04-11 2004-10-14 Pioneer Hi-Bred International, Inc. Method for reducing gene expression
WO2004092398A2 (en) 2003-04-15 2004-10-28 Basf Plant Science Gmbh Nucleic acid sequences encoding proteins associated with abiotic stress response and plant cells and plants with increased tolerance to environmental stress
US7598227B2 (en) 2003-04-16 2009-10-06 Isis Pharmaceuticals Inc. Modulation of apolipoprotein C-III expression
US7399853B2 (en) 2003-04-28 2008-07-15 Isis Pharmaceuticals Modulation of glucagon receptor expression
US7541344B2 (en) 2003-06-03 2009-06-02 Eli Lilly And Company Modulation of survivin expression
WO2004113496A2 (en) * 2003-06-20 2004-12-29 Isis Pharmaceuticals, Inc. Double stranded compositions comprising a 3’-endo modified strand for use in gene modulation
CA2533701A1 (en) 2003-07-31 2005-02-17 Isis Pharmaceuticals, Inc. Oligomeric compounds and compositions for use in modulation of small non-coding rnas
EP1654368A2 (en) 2003-08-01 2006-05-10 BASF Plant Science GmbH Process for the production of fine chemicals
CA2998666C (en) 2003-08-01 2022-04-12 Basf Plant Science Gmbh Method for the production of multiply-unsaturated fatty acids in transgenic organisms
MXPA06001622A (es) 2003-08-11 2006-07-03 Kweek En Researchbed Agrico Bv Plantas resistentes a hongos y sus usos.
US7825235B2 (en) 2003-08-18 2010-11-02 Isis Pharmaceuticals, Inc. Modulation of diacylglycerol acyltransferase 2 expression
US20050053981A1 (en) 2003-09-09 2005-03-10 Swayze Eric E. Gapped oligomeric compounds having linked bicyclic sugar moieties at the termini
JP4672664B2 (ja) 2003-09-18 2011-04-20 アイシス・ファーマシューティカルズ・インコーポレイテッド ｅＩＦ４Ｅ発現の調整
WO2005027962A1 (en) 2003-09-18 2005-03-31 Isis Pharmaceuticals, Inc. 4’-thionucleosides and oligomeric compounds
DK1678194T3 (da) 2003-10-10 2013-10-07 Alchemia Oncology Pty Ltd Modulering af syntese og degradering af hyaluronan i behandlingen af sygdom
CN102174538B (zh) 2003-10-23 2013-06-19 奇尼塔二有限责任公司 检测与抗病毒感染性有关的基因oas1中的突变的方法
US20050191653A1 (en) 2003-11-03 2005-09-01 Freier Susan M. Modulation of SGLT2 expression
SI2295073T1 (sl) 2003-11-17 2014-07-31 Genentech, Inc. Protitelo proti CD22 za zdravljenje tumorja hematopoetskega izvora
US20050120397A1 (en) * 2003-11-24 2005-06-02 Hermann Steller Compounds and methods for regulation of spermatid differentiation
US20070118931A1 (en) 2003-12-17 2007-05-24 Cropdesign N.V. Plants having modified growth characteristics and method for making the same
US7695932B2 (en) * 2003-12-24 2010-04-13 Massachusetts Institute Of Technology Gene targets for enhanced carotenoid production
US7741070B2 (en) 2003-12-24 2010-06-22 Massachusetts Institute Of Technology Gene targets for enhanced carotenoid production
US7608699B2 (en) * 2003-12-29 2009-10-27 Rockefeller University Synthetic nuclear localization signal derived from lentiviral integrase and methods of use thereof
EP2363480A3 (en) 2004-01-20 2015-10-07 Isis Pharmaceuticals, Inc. Modulation of glucocorticoid receptor expression
US7468431B2 (en) 2004-01-22 2008-12-23 Isis Pharmaceuticals, Inc. Modulation of eIF4E-BP2 expression
CA2556736C (en) 2004-02-25 2013-02-19 Pioneer Hi-Bred International, Inc. Novel bacillus thuringiensis crystal polypeptides, polynucleotides, and compositions thereof
EP1720988B1 (de) 2004-02-27 2011-10-12 BASF Plant Science GmbH Verfahren zur herstellung von ungesättigten omega-3-fettsäuren in transgenen organismen
US9458436B2 (en) 2004-02-27 2016-10-04 Basf Plant Science Gmbh Method for producing polyunsaturated fatty acids in transgenic plants
US8569474B2 (en) 2004-03-09 2013-10-29 Isis Pharmaceuticals, Inc. Double stranded constructs comprising one or more short strands hybridized to a longer strand
WO2005089268A2 (en) * 2004-03-15 2005-09-29 Isis Pharmaceuticals, Inc. Compositions and methods for optimizing cleavage of rna by rnase h
WO2005094370A2 (en) 2004-03-29 2005-10-13 The General Hospital Corporation Oligonucleotide complex compositions and methods of use as gene alteration tools
US20050267300A1 (en) 2004-04-05 2005-12-01 Muthiah Manoharan Processes and reagents for oligonucleotide synthesis and purification
US20050244869A1 (en) 2004-04-05 2005-11-03 Brown-Driver Vickie L Modulation of transthyretin expression
CN101014715A (zh) * 2004-04-22 2007-08-08 麒麟麦酒株式会社 转基因动物及其用途
US20070072815A1 (en) * 2004-05-04 2007-03-29 Kmiec Eric B Methods and kits to increase the efficiency of oligonucleotide-directed nucleic acid sequence alteration
US7825293B2 (en) 2004-05-28 2010-11-02 Cropdesign N.V. Plants having improved growth characteristics and a method for making the same
US8394947B2 (en) 2004-06-03 2013-03-12 Isis Pharmaceuticals, Inc. Positionally modified siRNA constructs
CA2569767C (en) 2004-06-09 2011-07-26 Pioneer Hi-Bred International, Inc. Plastid transit peptides
CA2559760A1 (en) 2004-07-02 2006-07-06 Metanomics Gmbh Process for the production of fine chemicals
WO2007087815A2 (en) 2004-12-17 2007-08-09 Metanomics Gmbh Process for the control of production of fine chemicals
US8680062B2 (en) 2004-07-06 2014-03-25 Deliversir Ltd. System for delivering therapeutic agents into living cells and cells nuclei
MX2007000410A (es) 2004-07-12 2007-03-28 Cropdesign Nv Plantas que tienen caracteristicas de crecimiento mejoradas y metodo para hacer las mismas.
WO2006013010A2 (en) 2004-07-31 2006-02-09 Metanomics Gmbh Preparation of organisms with faster growth and/or higher yield
DK2997980T3 (en) 2004-08-10 2018-03-26 Kastle Therapeutics Llc PROCEDURES FOR MODULATING LIPROPROTEIN AND CHOLESTEROL LEVELS
BRPI0514478A (pt) 2004-08-16 2008-06-17 Cropdesign Nv método para melhorar caracterìsticas de crescimento de plantas, plantas, construção, método para a produção de uma planta transgênica, planta transgênica, partes coletáveis, e, usos de um ácido nucleico/gene codificando proteìna de ligação de rna ou variante do mesmo ou uso de uma proteìna de ligação de rna ou homólogo da mesma, de um rbp1 ou variante do mesmo ou uso de um polipeptìdeo rbp1 ou homólogo do mesmo e de uma proteìna de ligação de rna ou variante da mesma ou uso de um rbp1 ou variante do mesmo
US7884086B2 (en) 2004-09-08 2011-02-08 Isis Pharmaceuticals, Inc. Conjugates for use in hepatocyte free uptake assays
WO2006030442A2 (en) 2004-09-16 2006-03-23 Gamida-Cell Ltd. Methods of ex vivo progenitor and stem cell expansion by co-culture with mesenchymal cells
WO2006034348A2 (en) 2004-09-17 2006-03-30 Isis Pharmaceuticals, Inc. Enhanced antisense oligonucleotides
EP1794184A2 (en) 2004-09-24 2007-06-13 BASF Plant Science GmbH Nucleic acid sequences encoding proteins associated with abiotic stress response and plant cells and plants with increased tolerance to environmental stress
ES2392449T3 (es) 2004-10-20 2012-12-10 Antisense Therapeutics Ltd Modulación antisentido de la expresión de la integrina alfa-4
DE602005025669D1 (de) 2004-10-29 2011-02-10 Cropdesign Nv Pflanzen mit veränderten wachstumseigenschaften und verfahren zu deren herstellung
AR051866A1 (es) 2004-12-24 2007-02-14 Cropdesign Nv Plantas con aumento del rendimiento y metodo de prepracion
EP2003205B1 (en) 2004-12-28 2013-05-01 Pioneer Hi-Bred International, Inc. Improved grain quality through altered expression of seed proteins
JP2008528014A (ja) 2005-01-27 2008-07-31 クロップデザイン エヌ．ブイ． 収量が増加した植物および該植物を作製する方法
WO2006091194A1 (en) 2005-02-23 2006-08-31 North Carolina State University Alteration of tobacco alkaloid content through modification of specific cytochrome p450 genes
EP2194140A2 (en) 2005-03-02 2010-06-09 Metanomics GmbH Process for the production of fine chemicals
US20140199313A1 (en) 2005-03-02 2014-07-17 Metanomics Gmbh Process for the Production of Fine Chemicals
EP2169058B1 (en) 2005-03-08 2013-01-23 BASF Plant Science GmbH Expression enhancing intron sequences
CN101175769A (zh) 2005-03-10 2008-05-07 健泰科生物技术公司 用于调控血管完整性的方法和组合物
DE102005013779A1 (de) 2005-03-22 2006-09-28 Basf Plant Science Gmbh Verfahren zur Herstellung von mehrfach ungesättigten C20- und C22-Fettsäuren mit mindestens vier Doppelbindungen in transgenen Pflanzen
EP1707632A1 (de) 2005-04-01 2006-10-04 Bayer CropScience GmbH Phosphorylierte waxy-Kartoffelstärke
CA2606270A1 (en) 2005-04-19 2006-10-26 Massachusetts Institute Of Technology Amphiphilic polymers and methods of use thereof
EP1874936B1 (en) 2005-04-19 2013-10-30 BASF Plant Science GmbH Improved methods controlling gene expression
US20070011752A1 (en) * 2005-05-06 2007-01-11 American Integrated Biologics, Inc. Production of human proteins in transgenic animal saliva
AU2006249522A1 (en) 2005-05-25 2006-11-30 Pioneer Hi-Bred International, Inc. Methods for improving crop plant architecture and yield
US9505867B2 (en) 2005-05-31 2016-11-29 Ecole Polytechmique Fédérale De Lausanne Triblock copolymers for cytoplasmic delivery of gene-based drugs
WO2006138145A1 (en) 2005-06-14 2006-12-28 Northwestern University Nucleic acid functionalized nanoparticles for therapeutic applications
AU2006260924B2 (en) 2005-06-23 2011-03-03 Basf Plant Science Gmbh Improved methods for the production of stably transformed, fertile zea mays plants
US8119858B2 (en) 2005-07-06 2012-02-21 Cropdesign N.V. Plant yield improvement by Ste20-like gene expression
DE102005038036A1 (de) 2005-08-09 2007-02-15 Basf Plant Science Gmbh Verfahren zur Herstellung von Arachidonsäure und/oder Eicosapentaensäure in transgenen Nutzpflanzen
CA2619411A1 (en) 2005-08-12 2007-02-22 Basf Plant Science Gmbh Nucleic acid sequences encoding proteins associated with abiotic stress response and plant cells and plants with increased tolerance to environmental stress
US7842856B2 (en) 2005-08-25 2010-11-30 The Board Of Trustees Of The University Of Illinois Herbicide resistance gene, compositions and methods
CN101268193A (zh) 2005-09-15 2008-09-17 克罗普迪塞恩股份有限公司 通过组3 lea表达的植物产量改良
EP2980220A1 (en) 2005-09-20 2016-02-03 BASF Plant Science GmbH Improved methods controlling gene expression
GB2431158A (en) 2005-10-13 2007-04-18 Rothamsted Res Ltd Process for the production of arachidonic and/or eicosapentaenoic acid
ES2555659T3 (es) 2005-11-07 2016-01-07 Cropdesign N.V. Plantas que tienen características de crecimiento mejoradas y un procedimiento de producción de las mismas
US8853492B2 (en) 2005-11-07 2014-10-07 Cropdesign N.V. Plants having improved growth characteristics and a method for making the same
CA2629953A1 (en) 2005-11-08 2007-05-18 Cropdesign N.V. Plants having improved growth characteristics and a method for making the same
AU2006311089C1 (en) * 2005-11-08 2012-11-08 Basf Plant Science Gmbh Use of armadillo repeat (ARM1) polynucleotides for obtaining pathogen resistance in plants
JP2009515522A (ja) 2005-11-10 2009-04-16 パイオニア ハイ−ブレッド インターナショナル， インコーポレイテッド Ｄｏｆ（ｄｎａｂｉｎｄｉｎｇｗｉｔｈｏｎｅｆｉｎｇｅｒ）配列および使用方法
US20070199096A1 (en) 2005-11-14 2007-08-23 E.I. Du Pont De Nemours And Company Compositions and Methods for Altering Alpha- and Beta-Tocotrienol Content
JP2009516710A (ja) 2005-11-21 2009-04-23 アイシス ファーマシューティカルズ， インコーポレーテッド ｅＩＦ４Ｅ−ＢＰ２の発現のモジュレート
US7723574B2 (en) 2005-11-24 2010-05-25 Basf Plant Science Gmbh Process for the production of Δ5-unsaturated fatty acids in transgenic organisms
WO2007060117A2 (de) * 2005-11-24 2007-05-31 Basf Se Chimäre keratinbindende effektorproteine
US8846393B2 (en) 2005-11-29 2014-09-30 Gamida-Cell Ltd. Methods of improving stem cell homing and engraftment
EP2166106B1 (en) 2005-12-01 2015-02-25 CropDesign N.V. Plants having improved growth characteristics and methods for making the same
WO2007074010A1 (en) 2005-12-24 2007-07-05 Teagasc Dairy Products Research Centre Process for the production of trans-10, cis 12 octadecadienoic acid
CN101437933B (zh) 2005-12-28 2013-11-06 斯克里普斯研究所 作为药物靶标的天然反义和非编码的rna转录物
US7592505B2 (en) 2005-12-30 2009-09-22 Pioneer Hi-Bred International, Inc. UDP-xylose synthases (UXS) polynucleotides, polypeptides, and uses thereof
NZ704098A (en) 2006-01-12 2015-02-27 Incima Ipco B V Epsps mutants
WO2007080143A1 (en) 2006-01-12 2007-07-19 Basf Plant Science Gmbh Use of stomatin (stm1) polynucleotides for achieving a pathogen resistance in plants
EP3210633B1 (en) 2006-01-26 2019-06-19 Ionis Pharmaceuticals, Inc. Compositions and their uses directed to huntingtin
DK1984381T3 (da) 2006-01-27 2010-11-01 Isis Pharmaceuticals Inc 6-modificerede bicycliske nukleinsyreanaloger
EP1984499B1 (en) 2006-01-27 2015-05-27 Isis Pharmaceuticals, Inc. Oligomeric compounds and compositions for the use in modulation of micrornas
US7569686B1 (en) 2006-01-27 2009-08-04 Isis Pharmaceuticals, Inc. Compounds and methods for synthesis of bicyclic nucleic acid analogs
CA2895745A1 (en) 2006-02-09 2007-08-16 Pioneer Hi-Bred International, Inc. Genes for enhancing nitrogen utilization efficiency in crop plants
GB0603160D0 (en) 2006-02-16 2006-03-29 Rothamsted Res Ltd Nucleic acid
US20090172834A1 (en) 2006-03-24 2009-07-02 Basf Plant Science Gmbh Proteins Associated With Abiotic Stress Response And Homologs
EP2441844A1 (en) 2006-03-31 2012-04-18 BASF Plant Science GmbH Plants having enhanced yield-related traits and a method for making the same
CA2644273A1 (en) 2006-04-05 2008-03-27 Metanomics Gmbh Process for the production of a fine chemical
WO2007124312A2 (en) 2006-04-19 2007-11-01 Pioneer Hi-Bred International, Inc. Isolated polynucleotide molecules corresponding to mutant and wild-type alleles of the maize d9 gene and methods of use
BRPI0711429A2 (pt) 2006-05-05 2012-10-16 Isis Pharmaceuticals Inc compostos e métodos para modulas expressão de gccr
US7666854B2 (en) 2006-05-11 2010-02-23 Isis Pharmaceuticals, Inc. Bis-modified bicyclic nucleic acid analogs
CA2651453C (en) 2006-05-11 2014-10-14 Isis Pharmaceuticals, Inc. 5'-modified bicyclic nucleic acid analogs
EP2377937A1 (en) 2006-05-30 2011-10-19 CropDesign N.V. Plants with reduced expression of a CLE-like gene having enhanced yield-related traits and a method for making the same
EP2497778A3 (en) 2006-05-31 2012-12-12 Metanomics GmbH Manipulation of the nitrogen metabolism
CA2649341A1 (en) 2006-06-08 2007-12-13 Basf Plant Science Gmbh Plants having improved growth characteristics and method for making the same
BRPI0712507A2 (pt) 2006-06-15 2011-07-05 Cropdesign Nv método para intensificar caracterìsticas relacionadas ao rendimento em plantas, planta ou parte da mesma, contrução uso de uma construção planta, parte de planta ou célula vegetal, método para a produção de uma planta transgência, partes colhìveis de um planta, produtos, uso de um ácido nucleico, molécula isolada de ácido nucleico, e, polipeptìdeo isolado
CA2654100A1 (en) 2006-06-15 2007-12-21 Cropdesign N.V. Use of nac transcription factor for enchancing yield-related traits in plants
CA2982638A1 (en) 2006-06-28 2008-01-03 Nucelis Inc. Fatty acid blends and uses therefor
WO2008011473A2 (en) 2006-07-19 2008-01-24 Isis Pharmaceuticals, Inc. Compositions and their uses directed to hbxip
ES2451669T3 (es) 2006-08-02 2014-03-28 Cropdesign N.V. Plantas que tienen características mejoradas y un procedimiento de fabricación de las mismas
EP2199396A1 (en) 2006-08-02 2010-06-23 CropDesign N.V. Plants transformed with SYT-polypeptide having increased yield under abiotic stress and a method for making the same
US8222486B2 (en) 2006-08-30 2012-07-17 Basf Plant Science Gmbh Method for increasing resistance to pathogens in transgenic plants
CN101610793B (zh) 2006-09-14 2012-10-24 迈德詹尼克斯医疗以色列有限公司 长效药物制剂
US8454948B2 (en) 2006-09-14 2013-06-04 Medgenics Medical Israel Ltd. Long lasting drug formulations
WO2008040787A2 (de) 2006-10-06 2008-04-10 Basf Plant Science Gmbh Verfahren zur herstellung mehrfach ungesättigter fettsäuren in transgenen organismen
US8329988B2 (en) 2006-10-12 2012-12-11 Basf Plant Science Gmbh Method for increasing pathogen resistance in transgenic plants
WO2008043849A2 (en) 2006-10-13 2008-04-17 Basf Plant Science Gmbh Plants with increased yield
CA2660439C (en) 2006-10-24 2016-02-16 Basf Plant Science Gmbh Methods for increasing the resistance in plants to biotropic fungi
AR064252A1 (es) 2006-11-16 2009-03-25 Cropdesign Nv Plantas que presentan caracteristicas acrecentadas relacionadas con el rendimiento y un metodo para producir las mismas
BRPI0718977A2 (pt) 2006-11-24 2014-02-04 Cropdesign Nv Método para aumentar rendimento de sementes em plantas em relação às plantas de controle, construção, uso da mesma, planta, parte de planta ou célula de planta, método para a produção de uma planta transgênica tendo redimento aumentado de sementes em relação às plantas de controle, planta transgênica, partes colhíveis de uma planta, produtos, e, uso de um ácido nucleico
US20100024067A1 (en) 2006-12-15 2010-01-28 Cropdesign N.V. Plants having enhanced seed yield-related traits and a method for making the same
WO2008074891A2 (en) 2006-12-21 2008-06-26 Basf Plant Science Gmbh Plants having enhanced yield-related traits and a method for method for making the same
EP1935428A1 (en) * 2006-12-22 2008-06-25 Antisense Pharma GmbH Oligonucleotide-polymer conjugates
EP2102364B1 (en) 2006-12-28 2019-01-23 Pioneer Hi-Bred International, Inc. Genetic markers for orobanche resistance in sunflower
CA2898230C (en) * 2007-01-10 2018-04-24 Purdue Research Foundation Polypeptide inhibitors of hsp27 kinase and uses therefor
EP2202314B1 (en) 2007-01-15 2014-03-12 BASF Plant Science GmbH Use of subtilisin (RNR9) polynucleotides for achieving a pathogen resistance in plants
WO2008092910A1 (en) 2007-01-30 2008-08-07 Cropdesign N.V. Plants having enhanced yield-related traits and a method for making the same
MX2009007308A (es) 2007-01-31 2009-07-15 Basf Plant Science Gmbh Plantas que tienen rasgos relacionados con el rendimiento mejorado y/o resistencia al estres abiotico aumentada y un metodo para obtener las mismas.
WO2008098248A2 (en) 2007-02-09 2008-08-14 Northwestern University Particles for detecting intracellular targets
KR101227432B1 (ko) 2007-02-28 2013-01-31 재단법인 작물유전체기능연구사업단 향상된 수확량 관련 형질을 갖는 식물 및 이의 제조 방법
CA2681661C (en) * 2007-03-23 2015-11-24 New York University Methods of increasing nitrogen-assimilation capacity in transgenic plants expressing cca1 and glk1
EP2574233A1 (en) 2007-04-04 2013-04-03 BASF Plant Science GmbH AHAS mutants
US9156865B2 (en) 2007-04-23 2015-10-13 Deliversir Ltd System for delivering therapeutic agents into living cells and cells nuclei
US9556210B2 (en) 2007-04-23 2017-01-31 Sabag-Rfa Ltd. System for delivering therapeutic agents into living cells and cells nuclei
PL2144633T3 (pl) * 2007-04-23 2015-02-27 Sabag Rfa Ltd Układ do transportu czynników terapeutycznych do żywych komórek i jąder komórkowych
CN104862333A (zh) 2007-05-03 2015-08-26 巴斯夫植物科学有限公司 具有增强的产量相关性状的植物和用于制备该植物的方法
EP2074220A2 (en) 2007-05-22 2009-07-01 BASF Plant Science GmbH Plant cells and plants with increased tolerance and/or resistance to environmental stress and increased biomass production-ko
DE112008001452T5 (de) 2007-05-22 2010-12-16 Basf Plant Science Gmbh Pflanzen mit erhöhter Toleranz und/oder Resistenz gegen Umweltstress und erhöhter Biomasseproduktion
US8878006B2 (en) 2007-05-23 2014-11-04 Crop Design N.V. Plants having enhanced yield-related traits and a method for making the same
CA2687211A1 (en) 2007-05-25 2008-12-04 Cropdesign N.V. Yield enhancement in plants by modulation of maize alfins
DK2826863T3 (en) 2007-05-30 2017-12-04 Univ Northwestern NUCLEIC ACID FUNCTIONALIZED NANOPARTICLES FOR THERAPEUTIC APPLICATIONS
US8278425B2 (en) 2007-05-30 2012-10-02 Isis Pharmaceuticals, Inc. N-substituted-aminomethylene bridged bicyclic nucleic acid analogs
US8278426B2 (en) 2007-06-08 2012-10-02 Isis Pharmaceuticals, Inc. Carbocyclic bicyclic nucleic acid analogs
AU2008270370A1 (en) 2007-06-29 2009-01-08 Basf Plant Science Gmbh Plants having enhanced yield-related traits and a method for making the same
CA2692579C (en) 2007-07-05 2016-05-03 Isis Pharmaceuticals, Inc. 6-disubstituted bicyclic nucleic acid analogs
ES2440265T3 (es) 2007-07-20 2014-01-28 Basf Plant Science Gmbh Plantas que tienen un aumento de características relacionadas con el rendimiento y un método para elaboración de las mismas
AR067748A1 (es) 2007-07-31 2009-10-21 Basf Plant Science Gmbh Plantas que tienen rasgos mejorados relacionados con el rendimiento y un metodo para obtenerlas
BRPI0813884A2 (pt) 2007-07-31 2014-10-07 Basf Plant Science Gmbh Método para intensificar características relacionadas com o rendimento em plantas com relação às plantas de controle, construção, uso de uma construção, planta, parte de planta ou célula de planta, método para a produção de uma planta transgênica, planta transgênica, partes colhíveis de uma planta, produtos, e, uso de um ácido nucleico.
WO2009021137A2 (en) 2007-08-07 2009-02-12 Purdue Research Foundation Kinase inhibitors and uses thereof
WO2009023855A2 (en) 2007-08-15 2009-02-19 Isis Pharmaceuticals, Inc. Tetrahydropyran nucleic acid analogs
WO2009034188A1 (en) 2007-09-14 2009-03-19 Basf Plant Science Gmbh Plants having increased yield-related traits and a method for making the same
CN101861393B (zh) 2007-09-18 2013-12-25 巴斯夫植物科学有限公司 产量提高的植物
WO2009039442A1 (en) 2007-09-21 2009-03-26 California Institute Of Technology Nfia in glial fate determination, glioma therapy and astrocytoma treatment
DE112008002456T5 (de) 2007-09-21 2011-01-13 Basf Plant Science Gmbh Pflanzen mit erhöhtem Ertrag
CA2700294A1 (en) 2007-09-21 2009-03-26 Basf Plant Science Gmbh Plants having increased yield-related traits and a method for making the same
BRPI0818295B1 (pt) 2007-10-05 2022-10-11 Cibus Europe B.V. Método para produção de planta resistente à herbicida
US20100280098A1 (en) * 2007-10-05 2010-11-04 Juliano Rudolph L Receptor targeted oligonucleotides
US20110071047A1 (en) * 2007-10-27 2011-03-24 O.D. 260 Inc. Promoter detection and analysis
US20090111099A1 (en) * 2007-10-27 2009-04-30 Yongsheng Ma Promoter Detection and Analysis
CN102936605A (zh) 2007-10-29 2013-02-20 巴斯夫植物科学有限公司 具有增强的产量相关性状的植物和用于制备该植物的方法
WO2009064771A2 (en) 2007-11-12 2009-05-22 North Carolina State University Alteration of tobacco alkaloid content through modification of specific cytochrome p450 genes
WO2009064920A2 (en) * 2007-11-13 2009-05-22 Isis Pharmaceuticals, Inc. Compounds and methods for modulating protein expression
WO2009067243A2 (en) 2007-11-20 2009-05-28 Isis Pharmaceuticals Inc. Modulation of cd40 expression
CN103952415A (zh) 2007-11-20 2014-07-30 先锋国际良种公司 用于改善植物应激耐性的玉米乙烯信号转导基因及其调节
US8546556B2 (en) * 2007-11-21 2013-10-01 Isis Pharmaceuticals, Inc Carbocyclic alpha-L-bicyclic nucleic acid analogs
CN103773795A (zh) 2007-11-22 2014-05-07 克罗普迪塞恩股份有限公司 具有增强的产量相关性状的植物及其生产方法
DE112008003225T5 (de) 2007-11-26 2012-06-06 Basf Plant Science Gmbh Pflanzen mit gesteigerten ertragsbezogenen Eigenschaften und Verfahren zur Herstellung derselben
WO2009077611A2 (en) * 2007-12-19 2009-06-25 Basf Plant Science Gmbh Plants with increased yield and/or increased tolerance to environmental stress (iy-bm)
DE112008003316T5 (de) 2007-12-20 2011-05-05 Basf Plant Science Gmbh Pflanzen mit gesteigerten ertragsbezogenen Eigenschaften und Verfahren zur Herstellung derselben
DE112008003433T5 (de) 2007-12-21 2010-11-04 Basf Plant Science Gmbh Pflanzen mit erhöhtem Ertrag (KO NUE)
JP2011508047A (ja) * 2007-12-27 2011-03-10 サイバス，エルエルシー アルキルエステル脂肪酸配合物およびその用途
BRPI0906617A2 (pt) 2008-01-25 2015-07-14 Basf Plant Science Gmbh Método para melhorar características relacionadas ao rendimento em plantas com relação às plantas controle, construto, uso de um construto, planta, parte da planta ou célula de planta, método para a produção de uma planta transgênica, planta transgênica, partes colhíveis de uma planta, produtos, e, uso de um ácido nucléico.
BRPI0906719A2 (pt) 2008-01-31 2015-08-04 Nat Inst For Biolog Sciences Método para alterar o crescimento e/ou desenvolvimento de planta, construção, uso de uma construção, planta, parte de planta ou célula de planta, método para a produção de uma planta transgênica, partes colhíveis de uma planta, produtos derivados de uma planta, e, uso de um ácido nucleico.
EP2265627A2 (en) 2008-02-07 2010-12-29 Isis Pharmaceuticals, Inc. Bicyclic cyclohexitol nucleic acid analogs
AR070719A1 (es) 2008-02-27 2010-04-28 Basf Plant Science Gmbh Plantas con mayor rendimiento, en terminos de crecimiento, desarrollo, acumulacion de biomasas y generacion de semillas en comparacion con una planta silvestre, y un metodo para producirlas.
US8426378B2 (en) 2008-03-21 2013-04-23 Isis Pharmaceuticals, Inc. Oligomeric compounds comprising tricyclic nucelosides and methods for their use
US9290534B2 (en) 2008-04-04 2016-03-22 Ionis Pharmaceuticals, Inc. Oligomeric compounds having at least one neutrally linked terminal bicyclic nucleoside
AR073534A1 (es) 2008-04-16 2010-11-17 Basf Plant Science Gmbh Plantas que tienen rasgos aumentados relacionados con el rendimiento y un metodo para obtenerlas
AU2009243552A1 (en) 2008-05-05 2009-11-12 Basf Plant Science Gmbh Plants having enhanced yield-related traits and a method for making the same
US10100334B2 (en) 2008-05-23 2018-10-16 Nucelis Inc. Production of squalene using yeast
AU2009259433A1 (en) 2008-06-20 2009-12-23 Basf Plant Science Gmbh Plants having enhanced yield-related traits and a method for making the same
BRPI0914689A2 (pt) 2008-06-26 2016-08-09 Basf Plant Science Gmbh métodos para intensificar as características relacionadas com o rendimento em plantas em relação às plantas de controle, e para a produção de uma planta transgênica, construto, uso de um construto, uso de um ácido nucleico, planta, parte da planta ou célula de planta, partes colhíveis de uma planta, e, produtos
EA201100146A1 (ru) 2008-07-04 2011-12-30 Басф Плант Сайенс Гмбх Растения, имеющие улучшенные характеристики урожайности, и способ их получения
BRPI0916207A2 (pt) 2008-07-17 2015-08-04 Basf Plant Science Gmbh Métodos para melhorar as características relacionadas com rendimento em plantas em relação às plantas de controle, e para produzir uma planta transgênica, construto, uso de um construto, planta, parte de planta ou célula de planta, planta trangênica, partes colhíveis de uma planta, produtos, uso de um ácido nucleico, molécula de ácido nucleico isolada, e, polipeptídeo isolado
CA2731038A1 (en) 2008-07-31 2010-02-04 Basf Plant Science Gmbh Plants having modified growth characteristics and a method for making the same
EP2942357A1 (en) 2008-08-04 2015-11-11 Glen N. Barber Sting (stimulator of inteferon genes), a regulator of innate immune responses
US20110154530A1 (en) 2008-08-19 2011-06-23 Basf Plant Science Gmbh Plants with Increased Yield by Increasing or Generating One or More Activities in a Plant or a Part Thereof
CA2733505A1 (en) 2008-08-20 2010-02-25 Basf Plant Science Gmbh Plants having enhanced yield-related traits and a method for making the same
MX2011002143A (es) 2008-08-25 2011-07-20 Excaliard Pharmaceuticals Inc Oligonucleotidos antisentido dirigidos contra el factor de crecimiento del tejido conectivo y usos de los mismos.
RU2011113978A (ru) 2008-09-11 2012-10-20 Киджин Н.В. (Nl) Способ создания диагностического маркера
CA2736473A1 (en) 2008-09-23 2010-04-01 Basf Plant Science Gmbh Plants with increased yield (lt)
WO2010036696A1 (en) 2008-09-24 2010-04-01 Isis Pharmaceuticals, Inc. Cyclohexenyl nucleic acid analogs
EA201100515A1 (ru) 2008-09-24 2012-02-28 Басф Плант Сайенс Гмбх Растения с улучшенными характеристиками урожайности и способ их получения
EP2356129B1 (en) 2008-09-24 2013-04-03 Isis Pharmaceuticals, Inc. Substituted alpha-l-bicyclic nucleosides
BRPI0919380A2 (pt) 2008-09-26 2015-08-18 Basf Agrochemical Products Bv Moléculas de ácido nucleico, vetores de expressão, bom como métodos para controlar ervas daninhas e para produzir uma planta brassica
LT2379084T (lt) 2008-10-15 2018-03-26 Ionis Pharmaceuticals, Inc. Faktoriaus 11 raiškos moduliavimas
AU2009322865B2 (en) * 2008-10-20 2013-07-18 Moerae Matrix, Inc. Polypeptide for treating or preventing adhesions
AR075466A1 (es) 2008-10-22 2011-04-06 Basf Se Uso de herbicidas tipo auxina en plantas cultivadas
WO2010046423A2 (en) 2008-10-22 2010-04-29 Basf Se Use of sulfonylurea herbicides on cultivated plants
EP2350287A2 (en) 2008-10-23 2011-08-03 BASF Plant Science GmbH A method for producing a transgenic cell with increased gamma-aminobutyric acid (gaba) content
DE112009002577T5 (de) 2008-10-23 2012-06-21 Basf Plant Science Gmbh Pflanzen mit erhöhtem Ertrag (NUE)
EP2447274B1 (en) 2008-10-24 2017-10-04 Ionis Pharmaceuticals, Inc. Oligomeric compounds and methods
WO2010048549A2 (en) 2008-10-24 2010-04-29 Isis Pharmaceuticals, Inc. 5' and 2' bis-substituted nucleosides and oligomeric compounds prepared therefrom
WO2010056519A1 (en) 2008-10-30 2010-05-20 Pioneer Hi-Bred International, Inc. Manipulation of glutamine synthetases (gs) to improve nitrogen use efficiency and grain yield in higher plants
EP2184351A1 (en) 2008-10-30 2010-05-12 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Polynucleotides encoding caryophyllene synthase and uses thereof
BRPI0921061A2 (pt) 2008-11-12 2016-07-19 Basf Plant Science Gmbh métodos para intensificar tolerância a estresse abiótico e/ou intensificar características relacionadas ao rendimento em plantas com relação a uma planta de controle, e para produzir uma planta transgênica com tolerância a estresse abiótico e/ou características relacionadas ao rendimento para uma planta de controle, partes colhíveis, produtos, construto, planta, parte de planta, ou célula de planta, usos de um construto, e de um ácido nucleico, molécula de ácido nucleico isolada, e, polipeptídeo isolado
CN102209785B (zh) 2008-11-14 2013-04-03 福建福大百特科技发展有限公司 一种耐热非-k12大肠杆菌植酸酶及其生产
DK2365803T3 (en) 2008-11-24 2018-01-22 Univ Northwestern POLYVALENT RNA NANOPARTICLE COMPOSITIONS
EP2960335A1 (en) 2008-12-03 2015-12-30 BASF Plant Science GmbH Plants having enhanced abiotic stress tolerance and/or enhanced yield-related traits and a method for making the same
WO2010065662A2 (en) 2008-12-04 2010-06-10 Curna, Inc. Treatment of sirtuin 1 (sirt1) related diseases by inhibition of natural antisense transcript to sirtuin 1
US8921329B2 (en) 2008-12-04 2014-12-30 Curna, Inc. Treatment of erythropoietin (EPO) related diseases by inhibition of natural antisense transcript to EPO
WO2010065867A1 (en) 2008-12-04 2010-06-10 Pioneer Hi-Bred International, Inc. Methods and compositions for enhanced yield by targeted expression of knotted1
EP2370582B1 (en) 2008-12-04 2017-05-10 CuRNA, Inc. Treatment of tumor suppressor gene related diseases by inhibition of natural antisense transcript to the gene
BRPI0922448A2 (pt) 2008-12-10 2021-02-17 Purdue Research Foundation inibidor com base em peptídeo penetrante celular de quinases
EP2376638B1 (en) 2008-12-12 2013-08-14 BASF Plant Science GmbH Desaturases and process for the production of polyunsaturated fatty acids in transgenic organisms
CN102317312A (zh) 2008-12-17 2012-01-11 巴斯夫植物科学有限公司 具有增强的产量相关性状和/或非生物胁迫耐受性的植物和用于制备此类植物的方法
EP2376633A1 (en) 2008-12-17 2011-10-19 AVI BioPharma, Inc. Antisense compositions and methods for modulating contact hypersensitivity or contact dermatitis
EP2204086A1 (en) 2009-01-02 2010-07-07 Leibniz-Institut für Pflanzengenetik und Kulturpflanzenforschung (IPK) Six row-type barley
US20100233270A1 (en) 2009-01-08 2010-09-16 Northwestern University Delivery of Oligonucleotide-Functionalized Nanoparticles
CA2749163A1 (en) 2009-01-14 2010-07-22 The Salk Institute For Biological Studies Methods for screening and compounds that protect against amyloid diseases
CN104232679A (zh) 2009-01-28 2014-12-24 巴斯夫植物科学有限公司 具有增强的产量相关性状的植物及其制备方法
US8536320B2 (en) 2009-02-06 2013-09-17 Isis Pharmaceuticals, Inc. Tetrahydropyran nucleic acid analogs
US20120021515A1 (en) 2009-02-06 2012-01-26 Swayze Eric E Oligomeric compounds and methods
KR101805199B1 (ko) 2009-02-12 2017-12-05 큐알엔에이, 인크. 신경교세포 유래된 신경영양성 인자 (ｇｄｎｆ)에 대한 자연 안티센스 전사체의 저해에 의한 신경교세포 유래된 신경영양성 인자 (ｇｄｎｆ) 관련된 질환의 치료
CA2752237C (en) 2009-02-12 2020-03-24 Opko Curna, Llc Treatment of brain derived neurotrophic factor (bdnf) related diseases by inhibition of natural antisense transcript to bdnf
DE112010000887T5 (de) 2009-02-25 2012-09-27 Basf Plant Science Company Gmbh Pflanzen mit gesteigerten Ertragsmerkmalen und Verfahren zu deren Herstellung
WO2010101818A1 (en) 2009-03-02 2010-09-10 Pioneer Hi-Bred International, Inc. Nac transcriptional activators involved in abiotic stress tolerance
EP2963116B1 (en) 2009-03-04 2020-11-11 CuRNA, Inc. Treatment of sirtuin 1 (sirt1) related diseases by inhibition of natural antisense transcript to sirt 1
ES2656290T3 (es) 2009-03-16 2018-02-26 Curna, Inc. Tratamiento de enfermedades relacionadas con el factor nuclear (derivado de eritroide 2) similar al 2 (NRF2) mediante inhibición del transcrito antisentido natural a NRF2
WO2010107740A2 (en) 2009-03-17 2010-09-23 Curna, Inc. Treatment of delta-like 1 homolog (dlk1) related diseases by inhibition of natural antisense transcript to dlk1
EP2419510B1 (en) 2009-04-14 2015-09-16 Pioneer Hi-Bred International Inc. Modulation of acc synthase improves plant yield under low nitrogen conditions
WO2010121956A1 (en) 2009-04-21 2010-10-28 Basf Plant Science Company Gmbh Rna-mediated induction of gene expression in plants
CN102803494A (zh) 2009-04-21 2012-11-28 巴斯夫植物科学有限公司 Rna介导的植物中基因表达的诱导
EP3248618A1 (en) 2009-04-22 2017-11-29 Massachusetts Institute Of Technology Innate immune suppression enables repeated delivery of long rna molecules
AU2010243730B2 (en) 2009-04-29 2016-04-21 Basf Plant Science Company Gmbh Plants having enhanced yield-related traits and a method for making the same
CN102459613A (zh) 2009-04-29 2012-05-16 巴斯夫植物科学有限公司 具有增强的产量相关性状的植物及其制备方法
DK2424987T3 (en) 2009-05-01 2018-02-26 Curna Inc TREATMENT OF HEMOGLOBIN (HBF / HBG) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPTION TO HBF / HBG
WO2010129501A1 (en) 2009-05-04 2010-11-11 Pioneer Hi-Bred International, Inc. Yield enhancement in plants by modulation of ap2 transcription factor
KR101835889B1 (ko) 2009-05-06 2018-03-08 큐알엔에이, 인크. 지질 수송 및 대사 유전자에 대한 천연 안티센스 전사체의 억제에 의해 지질 수송 및 대사 유전자 관련된 질환의 치료
WO2010129746A2 (en) 2009-05-06 2010-11-11 Curna, Inc. Treatment of tristetraproline (ttp) related diseases by inhibition of natural antisense transcript to ttp
CN102803291B (zh) 2009-05-06 2015-11-25 巴斯夫植物科学有限公司 具有增强的产量相关性状和/或增强的非生物胁迫耐受性的植物和制备其的方法
NO2432881T3 (zh) 2009-05-18 2018-04-14
KR101703695B1 (ko) 2009-05-22 2017-02-08 큐알엔에이, 인크. 전사 인자 ｅ3(ｔｆｅ3)에 대한 천연 안티센스 전사체의 억제에 의해 ｔｆｅ3 및 인슐린 수용체 기질 2(ｉｒｓ2)의 치료
US8791085B2 (en) 2009-05-28 2014-07-29 Curna, Inc. Treatment of antiviral gene related diseases by inhibition of natural antisense transcript to an antiviral gene
JP6128846B2 (ja) 2009-06-16 2017-05-17 クルナ・インコーポレーテッド パラオキソナーゼ（ｐｏｎ１）に対する天然アンチセンス転写物の抑制によるｐｏｎ１遺伝子関連疾患の治療
EP2443237B1 (en) 2009-06-16 2017-02-22 CuRNA, Inc. Treatment of collagen gene related diseases by inhibition of natural antisense transcript to a collagen gene
MX2011013544A (es) 2009-06-19 2012-02-21 Basf Plant Science Co Gmbh Plantas que tienen mejores rasgos relacionados con el rendimiento y un metodo para producirlas.
WO2010151671A2 (en) 2009-06-24 2010-12-29 Curna, Inc. Treatment of tumor necrosis factor receptor 2 (tnfr2) related diseases by inhibition of natural antisense transcript to tnfr2
CN102482672B (zh) 2009-06-26 2016-11-09 库尔纳公司 通过抑制唐氏综合征基因的天然反义转录物治疗唐氏综合征基因相关疾病
BRPI1008189A2 (pt) 2009-06-30 2015-08-25 Du Pont Planta transgenica semente transgenica obtida a partir da planta transgencia semente transgencia metodo de produção de uma planta transgenica metodo de produção de sementes transgenicas metodo de produto e ou subproduto da semente transgenica e semente transgenica obtida pelo metodo
ES2385451T3 (es) 2009-07-10 2012-07-25 Freie Universität Berlin Rock2 y Rock3, dos nuevas variantes de ganancia de función de los receptores de citoquinina AHK2 y AHK3
EP2275564A1 (en) 2009-07-17 2011-01-19 Freie Universität Berlin Means and method for the production of transgenic plants that are resistant to clubroot
AU2010275363A1 (en) 2009-07-23 2012-02-02 Basf Plant Science Company Gmbh Plants with increased yield
WO2011011273A1 (en) 2009-07-24 2011-01-27 Pioneer Hi-Bred International, Inc. The use of dimerization domain component stacks to modulate plant architecture
US9890195B2 (en) * 2009-07-27 2018-02-13 Purdue Research Foundation MK2 inhibitor compositions and methods to enhance neurite outgrowth, neuroprotection, and nerve regeneration
CN102762731B (zh) 2009-08-05 2018-06-22 库尔纳公司 通过抑制针对胰岛素基因(ins)的天然反义转录物来治疗胰岛素基因(ins)相关的疾病
WO2011017492A2 (en) 2009-08-05 2011-02-10 Pioneer Hi-Bred International, Inc. Novel eto1 genes and use of same for reduced ethylene and improved stress tolerance in plants
WO2011017521A2 (en) 2009-08-06 2011-02-10 Isis Pharmaceuticals, Inc. Bicyclic cyclohexose nucleic acid analogs
GB0914012D0 (en) 2009-08-11 2009-09-16 Plant Bioscience Ltd Stress tolerant plants
EP2949661A1 (en) 2009-08-19 2015-12-02 BASF Plant Science Company GmbH Plants having enhanced yield-related traits and a method for making the same
EP2467472A2 (en) 2009-08-20 2012-06-27 Pioneer Hi-Bred International Inc. Functional expression of yeast nitrate transporter (ynt1) in maize to improve nitrate uptake
US9023822B2 (en) 2009-08-25 2015-05-05 Curna, Inc. Treatment of 'IQ motif containing GTPase activating protein' (IQGAP) related diseases by inhibition of natural antisense transcript to IQGAP
CA3175433C (en) 2009-08-31 2024-05-28 Basf Plant Science Company Gmbh Regulatory nucleic acid molecules for enhancing constitutive gene expression in plants
RU2559534C2 (ru) 2009-08-31 2015-08-10 Басф Плант Сайенс Компани Гмбх Регуляторные молекулы нуклеиновых кислот для усиления семя-специфичной и/или семя-предпочтительной генной экспрессии в растениях
EP3178937B1 (en) 2009-08-31 2018-11-07 BASF Plant Science Company GmbH Regulatory nucleic acid molecules for enhancing seed-specific gene expression in plants promoting enhanced polyunsaturated fatty acid synthesis
ES2599076T3 (es) 2009-09-02 2017-01-31 Genentech, Inc. Smoothened mutante y métodos de utilización del mismo
MX2012003451A (es) 2009-09-25 2012-05-22 Basf Plant Science Co Gmbh Plantas que tienen rasgos mejorados relacionados con el rendimiento y un metodo para prepararlas.
EP2480674A1 (en) 2009-09-25 2012-08-01 BASF Plant Science Company GmbH Plants having enhanced yield-related traits and a method for making the same
MX2012003972A (es) 2009-10-02 2012-05-08 Pionner Hi Bred International Inc Regulacion a la baja de acc sintasa para mejorar el rendimiento de las plantas.
DE112010003738T5 (de) 2009-10-22 2013-08-14 Basf Plant Science Company Gmbh Pflanzen mit gesteigerten Ertragsmerkmalen und Verfahren zu deren Herstellung
MX2012004617A (es) 2009-10-22 2012-05-08 Genentech Inc Metodos y composiciones para modular activacion de hepsina de proteina que estimula macrofago.
AU2010313154B2 (en) 2009-10-30 2016-05-12 Northwestern University Templated nanoconjugates
AR078829A1 (es) 2009-10-30 2011-12-07 Du Pont Plantas y semillas con niveles alterados de compuesto de almacenamiento, construcciones relacionadas y metodos relacionados con genes que codifican proteinas similares a las aldolasas bacterianas de la clase ii del acido 2,4- dihidroxi-hept-2-eno-1,7-dioico
CA2779830C (en) 2009-11-13 2020-07-21 Avi Biopharma, Inc. Antisense antiviral compound and method for treating influenza viral infection
DE112010004383T5 (de) 2009-11-13 2012-08-23 Basf Plant Science Company Gmbh Pflanzen mit gesteigerten Ertragsmerkmalen und Verfahren zu deren Herstellung
WO2011061656A1 (en) 2009-11-17 2011-05-26 Basf Plant Science Company Gmbh Plants with increased yield
ES2625154T3 (es) * 2009-11-23 2017-07-18 Nucelis Llc Métodos y composiciones para producir escualeno empleando levaduras
AU2010324686B2 (en) 2009-11-30 2016-05-19 Genentech, Inc. Antibodies for treating and diagnosing tumors expressing SLC34A2 (TAT211 = SEQID2 )
JP6025567B2 (ja) 2009-12-16 2016-11-16 カッパーアールエヌエー，インコーポレイテッド 膜結合転写因子ペプチダーゼ、部位１（ｍｂｔｐｓ１）に対する天然アンチセンス転写物の阻害によるｍｂｔｐｓ１関連性疾患の治療
CN102781480B (zh) 2009-12-23 2018-07-27 库尔纳公司 通过抑制解偶联蛋白2(ucp2)的天然反义转录物而治疗ucp2相关疾病
KR101891352B1 (ko) 2009-12-23 2018-08-24 큐알엔에이, 인크. 간세포 성장 인자(ｈｇｆ)에 대한 천연 안티센스 전사체의 억제에 의한 ｈｇｆ 관련 질환의 치료
AU2010343143A1 (en) 2009-12-28 2012-06-28 Pioneer Hi-Bred International, Inc. Sorghum fertility restorer genotypes and methods of marker-assisted selection
EP2519633B1 (en) 2009-12-29 2017-10-25 CuRNA, Inc. Treatment of nuclear respiratory factor 1 (nrf1) related diseases by inhibition of natural antisense transcript to nrf1
CN102770540B (zh) 2009-12-29 2017-06-23 库尔纳公司 通过抑制肿瘤蛋白63(p63)的天然反义转录物而治疗p63相关疾病
WO2011082304A1 (en) 2009-12-31 2011-07-07 Pioneer Hi-Bred International, Inc. Engineering plant resistance to diseases caused by pathogens
CA2785832A1 (en) 2010-01-04 2011-07-07 Curna, Inc. Treatment of interferon regulatory factor 8 (irf8) related diseases by inhibition of natural antisense transcript to irf8
JP5963680B2 (ja) 2010-01-06 2016-08-03 カッパーアールエヌエー，インコーポレイテッド 膵臓発生遺伝子に対する天然アンチセンス転写物の阻害による膵臓発生遺伝子疾患の治療
MX2012007855A (es) 2010-01-06 2013-06-05 Du Pont Identificacion de ritmos diurnos en tejidos fotosinteticos del zea mays y uso en el mejoramiento de plantas de cultivo.
WO2011085102A1 (en) 2010-01-11 2011-07-14 Isis Pharmaceuticals, Inc. Base modified bicyclic nucleosides and oligomeric compounds prepared therefrom
CN102803493B (zh) 2010-01-11 2018-07-31 库尔纳公司 通过抑制性激素结合球蛋白(shbg)的天然反义转录物而治疗shbg相关疾病
US20110236325A1 (en) 2010-01-21 2011-09-29 NellOne Therapeutics, Inc. Methods to treat or prevent a skin condition using a nell1 peptide
CN102782135A (zh) 2010-01-25 2012-11-14 库尔纳公司 通过抑制rna酶h1的天然反义转录物而治疗rna酶h1相关疾病
WO2011094205A1 (en) 2010-01-26 2011-08-04 Pioneer Hi-Bred International, Inc. Hppd-inhibitor herbicide tolerance
RU2608496C2 (ru) 2010-02-22 2017-01-18 Курна, Инк. Лечение заболеваний, связанных с пирролин-5 карбоксилатредуктазой 1(pycr1), путем ингибирования природного антисмыслового транскрипта к pycr1
WO2011105902A2 (en) 2010-02-23 2011-09-01 Academisch Ziekenhuis Bij De Universiteit Van Amsterdam Antagonists of complement component 8-beta (c8-beta) and uses thereof
WO2011105901A2 (en) 2010-02-23 2011-09-01 Academisch Ziekenhuis Bij De Universiteit Van Amsterdam Antagonists of complement component 9 (c9) and uses thereof
WO2011105900A2 (en) 2010-02-23 2011-09-01 Academisch Ziekenhuis Bij De Universiteit Van Amsterdam Antagonists of complement component 8-alpha (c8-alpha) and uses thereof
PH12012501680A1 (en) 2010-02-23 2012-11-05 Genentech Inc Compositions and methods for the diagnosis and treatment of tumor
CA2788241A1 (en) 2010-02-24 2011-09-01 Basf Plant Science Company Gmbh Plants having enhanced yield-related traits and a method for making the same
EP2539453A2 (en) 2010-02-24 2013-01-02 BASF Plant Science Company GmbH Plants having enhanced yield-related traits and a method for making the same
EP2361985A1 (en) 2010-02-26 2011-08-31 BASF Plant Science Company GmbH Plants having enhanced yield-related traits and a method for making the same
EP2361927A1 (en) 2010-02-26 2011-08-31 BASF Plant Science Company GmbH Plants having enhanced yield-related traits and a method for making the same
BR112012022045A8 (pt) 2010-03-03 2018-06-19 Du Pont ''planta transgênica,semente transgênica,método para produzir uma planta transgênica,método para produzir sementes transgênicas,produto e/ou subproduto,polinucleotídeo isolado e planta ou semente''.
GB201003702D0 (en) 2010-03-05 2010-04-21 Univ Warwick Molecular engineering of a floral inducer for crop improvement
US9068185B2 (en) 2010-03-12 2015-06-30 Sarepta Therapeutics, Inc. Antisense modulation of nuclear hormone receptors
WO2011112732A2 (en) 2010-03-12 2011-09-15 The Brigham And Women's Hospital, Inc. Methods of treating vascular inflammatory disorders
US9193752B2 (en) 2010-03-17 2015-11-24 Isis Pharmaceuticals, Inc. 5′-substituted bicyclic nucleosides and oligomeric compounds prepared therefrom
AU2011228733A1 (en) 2010-03-18 2012-11-08 Basf Plant Science Company Gmbh Plants having enhanced yield-related traits and method for making the same
EA201290933A1 (ru) 2010-03-18 2013-05-30 Басф Плант Сайенс Компани Гмбх Растения с улучшенными характеристиками урожайности и способ их получения
BR112012023502A2 (pt) 2010-03-19 2015-09-01 Basf Plant Science Co Gmbh Método para otimizar características relacionadas ao rendimento em plantas em relação a plantas de controle, molécula de ácido nucleido isolada, polipetídeo isolado, uso de uma construção, planta, parte de uma planta ou célula de planta transformada, planta transgênica, método para a produção de uma planta transgênica, partes de uma planta passíveis de colheita, produtos derivados a partir de uma planta, uso de um ácido nucleico que codifica um polipetídeo e método para a produção de um produto
WO2011114312A1 (en) 2010-03-19 2011-09-22 Basf Plant Science Company Gmbh Plants having enhanced yield-related traits and method for making same
EP2371845A1 (en) 2010-03-22 2011-10-05 BASF Plant Science Company GmbH Plants having enhanced yield-related traits and a method for making the same
JP5978203B2 (ja) 2010-04-09 2016-08-24 カッパーアールエヌエー，インコーポレイテッド Ｆｇｆ２１に対する天然アンチセンス転写物の阻害による線維芽細胞増殖因子（ｆｇｆ２１）線維芽細胞増殖因子ｆｇｆ２１）関連疾患の治療
EP2385129A1 (en) 2010-05-03 2011-11-09 BASF Plant Science Company GmbH Enhanced methods for gene regulation in plants
US8980253B2 (en) 2010-04-26 2015-03-17 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-tRNA synthetase
AU2011248614B2 (en) 2010-04-27 2017-02-16 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl tRNA synthetases
AU2011248489B2 (en) 2010-04-28 2016-10-06 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl tRNA synthetases
EP3091027B1 (en) 2010-04-28 2018-01-17 Ionis Pharmaceuticals, Inc. 5' modified nucleosides and oligomeric compounds prepared therefrom
CN103154014B (zh) 2010-04-28 2015-03-25 Isis制药公司 修饰核苷、其类似物以及由它们制备的寡聚化合物
PL2563920T3 (pl) 2010-04-29 2017-08-31 Ionis Pharmaceuticals, Inc. Modulacja ekspresji transtyretyny
JP6008838B2 (ja) 2010-04-29 2016-10-19 エータイアー ファーマ， インコーポレイテッド アスパラギニルｔＲＮＡ合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見
AU2011248457B2 (en) 2010-04-29 2017-02-16 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl tRNA synthetases
AU2011248230B2 (en) 2010-05-03 2016-10-06 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of methionyl-tRNA synthetases
US8961961B2 (en) 2010-05-03 2015-02-24 a Tyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related protein fragments of arginyl-tRNA synthetases
KR101992076B1 (ko) 2010-05-03 2019-06-21 큐알엔에이, 인크. 시르투인 (sirt)에 대한 자연 안티센스 전사체의 저해에 의한 시르투인 (sirt) 관련된 질환의 치료
JP6008840B2 (ja) 2010-05-03 2016-10-19 エータイアー ファーマ， インコーポレイテッド フェニルアラニルαｔＲＮＡ合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見
AU2011248354A1 (en) 2010-05-03 2012-11-08 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
EP2566499B1 (en) 2010-05-04 2017-01-25 aTyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-trna synthetase complex
CN102971428A (zh) 2010-05-04 2013-03-13 巴斯夫欧洲公司 对除草剂具有增加的耐受性的植物
US20110277182A1 (en) 2010-05-06 2011-11-10 E.I. Dupont De Nemours And Company Maize acc synthase 3 gene and protein and uses thereof
GB201007834D0 (en) 2010-05-11 2010-06-23 Vib Vzw Growth promoting fusion proteins
WO2011143511A2 (en) 2010-05-12 2011-11-17 Columbia University Methods for producing enteroendocrine cells that make and secrete insulin
EP3023496B1 (en) 2010-05-13 2020-07-29 Sarepta Therapeutics, Inc. Compounds which modulate interleukins 17 and 23 signaling activity
EP2568996B1 (en) 2010-05-14 2017-10-04 aTyr Pharma, Inc. Therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-trna synthetases
TWI531370B (zh) 2010-05-14 2016-05-01 可娜公司 藉由抑制ｐａｒ４天然反股轉錄本治療ｐａｒ４相關疾病
US9034598B2 (en) 2010-05-17 2015-05-19 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-tRNA synthetases
KR20180053419A (ko) 2010-05-26 2018-05-21 큐알엔에이, 인크. 무조(無調)의 동소체 1 (atoh1)에 대한 자연 안티센스 전사체의 저해에 의한 atoh1 관련된 질환의 치료
EP2575856B1 (en) 2010-05-27 2017-08-16 aTyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutaminyl-trna synthetases
WO2011156278A1 (en) 2010-06-07 2011-12-15 Isis Pharmaceuticals, Inc. Bicyclic nucleosides and oligomeric compounds prepared therefrom
EP2580228B1 (en) 2010-06-08 2016-03-23 Ionis Pharmaceuticals, Inc. Substituted 2'-amino and 2'-thio-bicyclic nucleosides and oligomeric compounds prepared therefrom
EP2582396A4 (en) 2010-06-15 2014-01-01 Medgenics Medical Israel Ltd REMEDY FORMULATIONS WITH LONG-TERM EFFECT
AU2011268559A1 (en) 2010-06-24 2013-02-14 Basf Plant Science Company Gmbh Plants having enhanced yield-related traits and method for making the same
CA2801688A1 (en) 2010-06-25 2011-12-29 Basf Plant Science Company Gmbh Plants with enhanced yield-related traits and producing method thereof
AU2011271497A1 (en) 2010-07-01 2013-01-10 E. I. Du Pont De Nemours And Company Plant seeds with altered storage compound levels, related constructs and methods involving genes encoding PAE and PAE-like polypeptides
WO2012004013A2 (en) 2010-07-08 2012-01-12 Bayer Bioscience N.V. Glucosinolate transporter protein and uses thereof
WO2012021247A2 (en) 2010-07-12 2012-02-16 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-trna synthetases
EP2593547B1 (en) 2010-07-14 2017-11-15 CuRNA, Inc. Treatment of discs large homolog (dlg) related diseases by inhibition of natural antisense transcript to dlg
AU2011277925A1 (en) 2010-07-16 2013-02-21 Basf Plant Science Company Gmbh Plants having enhanced yield-related traits and method for making the same
US20120122223A1 (en) 2010-08-03 2012-05-17 Cibus Us Llc Mutated protoporphyrinogen ix oxidase (ppx) genes
UA112969C2 (uk) 2010-08-03 2016-11-25 Сібас Юс Ллс Рослина, стійка до одного або більше ррх-інгібуючих гербіцидів, яка містить мутантний ген протопорфіриноген ix оксидази (ррх)
CN103237894A (zh) 2010-08-13 2013-08-07 先锋国际良种公司 包含具有羟基苯丙酮酸双加氧酶(hppd)活性的序列的组合物和方法
MX2013002137A (es) 2010-08-24 2013-05-17 Basf Plant Science Co Gmbh Plantas que tienen mejores rasgos relacionados con el rendimiento y un metodo para prepararlas.
US9029506B2 (en) 2010-08-25 2015-05-12 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of tyrosyl-tRNA synthetases
EP2426204A1 (en) 2010-09-02 2012-03-07 Ludwig-Maximilians-Universität München Spontaneous nodule organogenesis in plants
WO2012028673A1 (en) 2010-09-02 2012-03-08 Ludwig-Maximilians-Universitaet Muenchen Spontaneous organogenesis in plants
DK2625197T3 (en) 2010-10-05 2016-10-03 Genentech Inc Smoothened MUTANT AND METHODS OF USING THE SAME
RU2624048C2 (ru) 2010-10-06 2017-06-30 Курна, Инк. Лечение заболеваний, связанных с геном сиалидазы 4 (neu4), путем ингибирования природного антисмыслового транскрипта гена neu4
WO2012048113A2 (en) 2010-10-07 2012-04-12 The General Hospital Corporation Biomarkers of cancer
RU2597972C2 (ru) 2010-10-22 2016-09-20 Курна Инк. Лечение заболеваний, связанных с геном альфа-l-идуронидазы (idua), путем ингибирования природного антисмыслового транскрипта гена idua
KR101913232B1 (ko) 2010-10-27 2018-10-30 큐알엔에이, 인크. 인터페론-관련된 발달성 조절물질 1 (ifrd1)에 대한 자연 안티센스 전사체의 저해에 의한 ifrd1 관련된 질환의 치료
MX2013005236A (es) 2010-11-10 2013-06-28 Basf Plant Science Co Gmbh Plantas que tienen mejores rasgos relacionados con el rendimiento y un metodo para producirlas.
EP2638163B1 (en) 2010-11-12 2017-05-17 The General Hospital Corporation Polycomb-associated non-coding rnas
US8609621B2 (en) 2010-11-15 2013-12-17 E I Du Pont De Nemours And Company Acid-cleavable linkers exhibiting altered rates of acid hydrolysis
EP2640853B1 (en) 2010-11-17 2018-12-26 Ionis Pharmaceuticals, Inc. Modulation of alpha synuclein expression
JP6071893B2 (ja) 2010-11-23 2017-02-01 カッパーアールエヌエー，インコーポレイテッド Ｎａｎｏｇへの天然アンチセンス転写物の阻害によるｎａｎｏｇ関連疾患の治療
BR112013014037A2 (pt) 2010-12-06 2017-06-06 Basf Plant Science Co Gmbh método para a produção de uma ou mais moléculas de ácido nucleico, molécula de ácido nucleico reguladora, construto de expressão, vetor, micro-organismo, célula de planta ou célula animal e planta
ES2903230T3 (es) 2010-12-16 2022-03-31 Basf Agro Bv Plantas que tienen mayor tolerancia a los herbicidas
CA2823467C (en) 2010-12-22 2020-10-27 Pioneer Hi-Bred International, Inc. Qtls associated with and methods for identifying whole plant field resistance to sclerotinia
EP2663323B1 (en) 2011-01-14 2017-08-16 The General Hospital Corporation Methods targeting mir-128 for regulating cholesterol/lipid metabolism
WO2012098517A1 (en) 2011-01-20 2012-07-26 Basf Plant Science Company Gmbh Plants having enhanced yield-related traits and method for making the same
WO2012101599A2 (en) 2011-01-27 2012-08-02 Ramot At Tel-Aviv University Ltd. Glycogen synthase kinase-3 inhibitors
EP2668200B1 (en) 2011-01-27 2017-03-15 Ramot at Tel-Aviv University Ltd. Glycogen synthase kinase-3 inhibitors
CN107603960A (zh) 2011-02-01 2018-01-19 科罗拉多小麦研究基金会公司 乙酰辅酶a羧化酶除草剂抗性植物
CN103391777A (zh) 2011-02-02 2013-11-13 普林斯顿大学理事会 作为病毒产生调节剂的去乙酰化酶调节剂
HUE044178T4 (hu) 2011-02-02 2019-10-28 Excaliard Pharmaceuticals Inc Kötõszöveti növekedési faktort (CTGF) célzó antiszensz vegyületek keloidok vagy hipertrófiás hegek kezelési eljárásban történõ alkalmazásra
US9273336B2 (en) 2011-02-21 2016-03-01 E. I. Du Pont De Nemours And Company Recombinant host cells having an increase in buoyant density
AR085394A1 (es) 2011-02-25 2013-09-25 Univ Nac De La Plata Unlp Proteasa de plantas
WO2012117330A1 (en) 2011-02-28 2012-09-07 Basf Plant Science Company Gmbh Plants having enhanced yield-related traits and producing methods thereof
PH12013501769A1 (en) 2011-02-28 2013-10-14 Basf Plant Science Co Gmbh Plants having enhanced yield-related traits and producing methods thereof
CN103582702A (zh) 2011-03-01 2014-02-12 巴斯夫植物科学有限公司 具有增强的产量相关性状的植物和用于制备该植物的方法
CA2832910C (en) 2011-04-12 2019-07-02 Cynthia Lander Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
US9890200B2 (en) 2011-04-12 2018-02-13 Moerae Matrix, Inc. Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
WO2012148835A1 (en) 2011-04-29 2012-11-01 Pioneer Hi-Bred International, Inc. Down-regulation of a homeodomain-leucine zipper i-class homeobox gene for improved plant performance
WO2012156760A1 (en) 2011-05-19 2012-11-22 Consejo Superior De Investigaciones Cientificas Process for modifying the architecture and improving the yield of crop plants
EP2718439B1 (en) 2011-06-09 2017-08-09 CuRNA, Inc. Treatment of frataxin (fxn) related diseases by inhibition of natural antisense transcript to fxn
WO2012170347A1 (en) 2011-06-09 2012-12-13 Isis Pharmaceuticals, Inc. Bicyclic nucleosides and oligomeric compounds prepared therefrom
EP2721160A2 (en) 2011-06-14 2014-04-23 Synthon Biopharmaceuticals B.V. Compositions and methods for making and biocontaining auxotrophic transgenic plants
WO2013009935A2 (en) 2011-07-12 2013-01-17 Two Blades Foundation Late blight resistance genes
BR112014000580A2 (pt) 2011-07-15 2017-03-01 Syngenta Participations Ag métodos para aumento da produtividade e tolerância ao estresse em uma planta
WO2013012643A1 (en) 2011-07-15 2013-01-24 Syngenta Participations Ag Polynucleotides encoding trehalose-6-phosphate phosphatase and methods of use thereof
WO2013017982A1 (en) 2011-08-01 2013-02-07 Basf Plant Science Company Gmbh Method for identification and isolation of terminator sequences causing enhanced transcription
ES2856091T3 (es) 2011-09-14 2021-09-27 Univ Northwestern Nanoconjugados capaces de atravesar la barrera hematoencefálica
DK2756080T3 (da) 2011-09-14 2019-05-20 Translate Bio Ma Inc Multimeriske oligonukleotidforbindelser
CN104011210B (zh) 2011-10-11 2018-05-01 布里格姆及妇女医院股份有限公司 神经退行性病症中的microRNA
US20150082480A1 (en) 2011-10-25 2015-03-19 Pioneer Hi Bred International Inc Methods to alter plant cell wall composition for improved biofuel production and silage digestibility
US20150159166A1 (en) 2011-10-31 2015-06-11 Pioneer Hi Bred International Inc Plant drought tolerance and nitrogen use efficiency by reducing plant sensitivity to ethylene
EP2790736B1 (en) 2011-12-12 2018-01-31 Oncoimmunin, Inc. In vivo delivery of oligonucleotides
SG11201404608WA (en) 2012-02-13 2014-09-26 Gamida Cell Ltd Mesenchymal stem cells conditioned medium and methods of generating and using the same
WO2013134636A1 (en) 2012-03-09 2013-09-12 Purdue Research Foundation Compositions and methods for delivery of kinase inhibiting peptides
WO2013138309A1 (en) 2012-03-13 2013-09-19 Pioneer Hi-Bred International, Inc. Genetic reduction of male fertility in plants
WO2013138358A1 (en) 2012-03-13 2013-09-19 Pioneer Hi-Bred International, Inc. Genetic reduction of male fertility in plants
PT2825648T (pt) 2012-03-15 2018-11-09 Scripps Research Inst Tratamento de doenças relacionadas ao fator neurotrófico derivado do cerebro (bdnf) por inibição da transcrição anti-sentido natural ao bdnf
CA2907072A1 (en) 2012-03-16 2013-09-19 Valerion Therapeutics, Llc Antisense conjugates for decreasing expression of dmpk
WO2013154799A1 (en) 2012-04-09 2013-10-17 Isis Pharmaceuticals, Inc. Tricyclic nucleosides and oligomeric compounds prepared therefrom
WO2013154798A1 (en) 2012-04-09 2013-10-17 Isis Pharmaceuticals, Inc. Tricyclic nucleic acid analogs
CA2871073A1 (en) 2012-04-20 2013-10-24 Aptamir Therapeutics, Inc. Mirna modulators of thermogenesis
EP2841572B1 (en) 2012-04-27 2019-06-19 Duke University Genetic correction of mutated genes
KR102028784B1 (ko) 2012-05-16 2019-10-04 트랜슬레이트 바이오 인코포레이티드 유전자 발현을 조절하기 위한 조성물 및 방법
KR20150030205A (ko) 2012-05-16 2015-03-19 라나 테라퓨틱스, 인크. Smn 유전자 패밀리 발현을 조절하기 위한 조성물 및 방법
US10045499B2 (en) 2012-05-24 2018-08-14 Iowa State University Research Foundation, Inc. Arabidopsis nonhost resistance gene(s) and use thereof to engineer disease resistant plants
WO2013184209A1 (en) 2012-06-04 2013-12-12 Ludwig Institute For Cancer Research Ltd. Mif for use in methods of treating subjects with a neurodegenerative disorder
AR091489A1 (es) 2012-06-19 2015-02-11 Basf Se Plantas que tienen una mayor tolerancia a herbicidas inhibidores de la protoporfirinogeno oxidasa (ppo)
EP2677035A1 (en) 2012-06-22 2013-12-25 BASF Plant Science Company GmbH Plants having enhanced yield-related traits and a method for making the same
US9567569B2 (en) 2012-07-23 2017-02-14 Gamida Cell Ltd. Methods of culturing and expanding mesenchymal stem cells
US9175266B2 (en) 2012-07-23 2015-11-03 Gamida Cell Ltd. Enhancement of natural killer (NK) cell proliferation and activity
CA2880833A1 (en) 2012-08-03 2014-02-06 Aptamir Therapeutics, Inc. Cell-specific delivery of mirna modulators for the treatment of obesity and related disorders
EP2885312A4 (en) 2012-08-15 2016-01-20 Isis Pharmaceuticals Inc PROCESS FOR PREPARING OLIGOMERIC COMPOUNDS USING MODIFIED CAPTURE PROTOCOLS
EP2885411B1 (en) 2012-08-16 2018-12-05 VIB vzw Means and methods for altering the lignin pathway in plants
WO2014037735A1 (en) 2012-09-10 2014-03-13 University Of Leicester Atsp1, an e3 ubiquitin ligase, and its use
US9029335B2 (en) 2012-10-16 2015-05-12 Isis Pharmaceuticals, Inc. Substituted 2′-thio-bicyclic nucleosides and oligomeric compounds prepared therefrom
EP2908864B1 (en) 2012-10-22 2019-12-11 Sabag-Rfa Ltd. Phosphate compounds for delivering therapeutic agents into living cells and cells nuclei
WO2014081673A2 (en) 2012-11-20 2014-05-30 Pioneer Hi-Bred International, Inc. Engineering plants for efficient uptake and utilization of urea to improve crop production
CA2894213A1 (en) 2012-12-21 2014-06-26 Pioneer Hi-Bred International, Inc. Compositions and methods for auxin-analog conjugation
EP2754715A1 (en) 2013-01-11 2014-07-16 Consejo Superior De Investigaciones Científicas (CSIC) Stress tolerant plants
US10435705B2 (en) 2013-01-29 2019-10-08 Basf Plant Science Company Gmbh Fungal resistant plants expressing HCP6
WO2014117988A1 (en) 2013-01-29 2014-08-07 Basf Plant Science Company Gmbh Fungal resistant plants expressing hcp7
US10231397B2 (en) 2013-01-29 2019-03-19 Basf Plant Science Company Gmbh Fungal resistant plants expressing EIN2
WO2014121436A1 (en) 2013-02-05 2014-08-14 Plant Bioscience Limited Transgenic plants
WO2014135682A1 (en) 2013-03-08 2014-09-12 Basf Plant Science Company Gmbh Fungal resistant plants expressing mybtf
US20160002648A1 (en) 2013-03-11 2016-01-07 Mei Guo Genes for improving nutrient uptake and abiotic stress tolerance in plants
US9803214B2 (en) 2013-03-12 2017-10-31 Pioneer Hi-Bred International, Inc. Breeding pair of wheat plants comprising an MS45 promoter inverted repeat that confers male sterility and a construct that restores fertility
RU2694686C2 (ru) 2013-03-12 2019-07-16 Е.И.Дюпон Де Немур Энд Компани Способы идентификации вариантных сайтов распознавания для редкощепящих сконструированных средств для индукции двунитевого разрыва, и композиции с ними, и их применения
WO2014164116A1 (en) 2013-03-13 2014-10-09 Pioneer Hi-Bred International, Inc. Functional expression of bacterial major facilitator superfamily (sfm) gene in maize to improve agronomic traits and grain yield
US20160010101A1 (en) 2013-03-13 2016-01-14 Pioneer Hi-Bred International, Inc. Enhanced nitrate uptake and nitrate translocation by over- expressing maize functional low-affinity nitrate transporters in transgenic maize
UA119745C2 (uk) 2013-03-14 2019-08-12 Сібас Юс Ллс Мутований ген аленоксидсинтази 2 (aos2)
BR112015023304A2 (pt) 2013-03-14 2017-07-18 Pioneer Hi Bred Int método para melhorar a tolerância ao estresse abiótico de uma planta, planta e semente
US9957515B2 (en) 2013-03-15 2018-05-01 Cibus Us Llc Methods and compositions for targeted gene modification
AU2014233519B2 (en) * 2013-03-15 2020-05-14 Cibus Europe B.V. Methods and compositions for increasing efficiency of targeted gene modification using oligonucleotide-mediated gene
US20160017350A1 (en) 2013-03-15 2016-01-21 Pioneer Hi-Bred International, Inc. Compositions and methods of use of acc oxidase polynucleotides and polypeptides
MY191390A (en) 2013-03-15 2022-06-22 Cibus Us Llc Methods and compositions for increasing efficiency of increased efficiency of targeted gene modification using oligonucleotide-mediated gene repair
WO2014152507A2 (en) 2013-03-15 2014-09-25 Pioneer Hi-Bred International, Inc. Modulation of acc deaminase expression
US9828582B2 (en) 2013-03-19 2017-11-28 Duke University Compositions and methods for the induction and tuning of gene expression
WO2014147249A1 (en) 2013-03-21 2014-09-25 Vib Vzw Means and methods for the reduction of photorespiration in crops
IL296543B2 (en) 2013-05-01 2025-02-01 Ionis Pharmaceuticals Inc Compositions and methods for modulating HBV and TTR expression
JP6869720B2 (ja) 2013-06-13 2021-05-12 アンチセンス セラピューティクス リミテッド 併用療法
EP2816115A1 (en) 2013-06-17 2014-12-24 BASF Plant Science Company GmbH Plants having one or more enhanced yield-related traits and a method for making the same
EP3013850B1 (en) 2013-06-24 2018-07-25 Ramot at Tel-Aviv University Ltd. Glycogen synthase kinase-3 inhibitors
US11459579B2 (en) 2013-07-09 2022-10-04 Board Of Trustees Of Michigan State University Transgenic plants produced with a K-domain, and methods and expression cassettes related thereto
WO2015006105A1 (en) 2013-07-09 2015-01-15 Board Of Trustees Of Michigan State University Transgenic plants produced with a k-domain, and methods and expression cassettes related thereto
US11162096B2 (en) 2013-10-14 2021-11-02 Ionis Pharmaceuticals, Inc Methods for modulating expression of C9ORF72 antisense transcript
CA2844640A1 (en) 2013-12-06 2015-06-06 The University Of British Columbia Method for treatment of castration-resistant prostate cancer
EP2896698A1 (en) 2014-01-17 2015-07-22 BASF Plant Science Company GmbH Plants having one or more enhanced yield-related traits and a method for making the same
US20170166920A1 (en) 2014-01-30 2017-06-15 Two Blades Foundation Plants with enhanced resistance to phytophthora
DK3099333T3 (da) 2014-01-31 2021-02-01 Univ Temple Bag3 som mål for behandling af hjertesvigt
EP3102197B1 (en) 2014-02-04 2018-08-29 Genentech, Inc. Mutant smoothened and methods of using the same
IL247679B2 (en) 2014-03-14 2024-11-01 Cibus Europe Bv Methods and compositions for increasing efficiency of targeted gene modification using oligonucleotide-mediated gene repair
WO2015142910A1 (en) 2014-03-17 2015-09-24 Isis Pharmaceuticals, Inc. Bicyclic carbocyclic nucleosides and oligomeric compounds prepared therefrom
US10006027B2 (en) 2014-03-19 2018-06-26 Ionis Pharmaceuticals, Inc. Methods for modulating Ataxin 2 expression
WO2015143246A1 (en) 2014-03-19 2015-09-24 Isis Pharmaceuticals, Inc. Compositions for modulating ataxin 2 expression
PT3126499T (pt) 2014-04-01 2020-08-31 Biogen Ma Inc Composições para modulação da expressão de sod-1
WO2015150465A2 (en) 2014-04-03 2015-10-08 Basf Se Plants having increased tolerance to herbicides
US10221416B2 (en) 2014-04-24 2019-03-05 Ionis Pharmaceuticals, Inc. Oligomeric compounds comprising alpha-beta-constrained nucleic acid
PL3608406T3 (pl) 2014-05-01 2023-05-22 Ionis Pharmaceuticals, Inc. Kompozycje i sposoby modulowania ekspresji czynnika B dopełniacza
WO2015171603A1 (en) 2014-05-06 2015-11-12 Two Blades Foundation Methods for producing plants with enhanced resistance to oomycete pathogens
EP3508198A1 (en) 2014-06-04 2019-07-10 Exicure, Inc. Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applications
CA2950878C (en) 2014-06-10 2024-01-23 Erasmus University Medical Center Rotterdam Antisense oligonucleotides useful in treatment of pompe disease
WO2015200697A1 (en) 2014-06-25 2015-12-30 The General Hospital Corporation Targeting human satellite ii (hsatii)
WO2015200901A1 (en) 2014-06-26 2015-12-30 The Trustees Of Columbia University In The City Of New York Inhibition of serotonin expression in gut enteroendocrine cells results in conversion to insulin-positive cells
CA2954201A1 (en) 2014-07-08 2016-01-14 Vib Vzw Means and methods to increase plant yield
WO2016011029A2 (en) 2014-07-14 2016-01-21 Washington State University Nanos knock-out that ablates germline cells
WO2016033424A1 (en) 2014-08-29 2016-03-03 Genzyme Corporation Methods for the prevention and treatment of major adverse cardiovascular events using compounds that modulate apolipoprotein b
BR112017004056A2 (pt) 2014-09-12 2017-12-05 Biogen Ma Inc composições e métodos para detecção da proteína smn em um indivíduo e tratamento de um indivíduo
EP3198012B1 (en) 2014-09-26 2019-09-04 University of Massachusetts Rna-modulating agents
WO2016057515A2 (en) 2014-10-06 2016-04-14 Altria Client Services Llc Genetic control of axillary bud growth in tobacco plants
CN107106650A (zh) 2014-11-17 2017-08-29 莫伊莱麦屈克斯公司 用于预防或治疗表征为异常的成纤维细胞增殖和细胞外基质沉积的疾病、状况或过程的组合物和方法
WO2016081911A2 (en) 2014-11-21 2016-05-26 Northwestern University The sequence-specific cellular uptake of spherical nucleic acid nanoparticle conjugates
WO2016100309A1 (en) 2014-12-16 2016-06-23 Pioneer Hi-Bred International, Inc. Restoration of male fertility in wheat
US9688707B2 (en) 2014-12-30 2017-06-27 Ionis Pharmaceuticals, Inc. Bicyclic morpholino compounds and oligomeric compounds prepared therefrom
US10793855B2 (en) 2015-01-06 2020-10-06 Ionis Pharmaceuticals, Inc. Compositions for modulating expression of C9ORF72 antisense transcript
US10538763B2 (en) 2015-01-16 2020-01-21 Ionis Pharmaceuticals, Inc. Compounds and methods for modulation of DUX4
BR112017015270B1 (pt) 2015-01-21 2023-10-24 Basf Se Método para controle de ervas daninhas, molécula de ácido nucleico, cassete de expressão, vetor e polipeptídeo tria mutante
US10793868B2 (en) 2015-02-03 2020-10-06 Institute Of Genetics And Developmental Biology Chinese Academy Of Sciences Plants with increased seed size
WO2016124920A1 (en) 2015-02-03 2016-08-11 The Institute Of Genetics And Developmental Biology Rice plants with altered seed phenotype and quality
CN107429259A (zh) 2015-02-04 2017-12-01 巴斯夫植物科学有限公司 通过增加莨菪亭含量，增加转基因植物中大豆锈病抗性的方法
GB201501941D0 (en) 2015-02-05 2015-03-25 British American Tobacco Co Method
JP6929791B2 (ja) 2015-02-09 2021-09-01 デューク ユニバーシティ エピゲノム編集のための組成物および方法
WO2016128470A1 (en) 2015-02-11 2016-08-18 Basf Se Herbicide-resistant hydroxyphenylpyruvate dioxygenases
GB201502409D0 (en) 2015-02-13 2015-04-01 British American Tobacco Co Method
US11129844B2 (en) 2015-03-03 2021-09-28 Ionis Pharmaceuticals, Inc. Compositions and methods for modulating MECP2 expression
EP3268022A4 (en) 2015-03-12 2018-11-21 Moerae Matrix, Inc., Use of mk2 inhibitor peptide-containing compositions for treating non-small cell lung cancer with same
MY186899A (en) 2015-03-18 2021-08-26 Basf Se Recombinant microorganism for improved production of fine chemicals
WO2016164463A1 (en) 2015-04-07 2016-10-13 The General Hospital Corporation Methods for reactivating genes on the inactive x chromosome
US10407678B2 (en) 2015-04-16 2019-09-10 Ionis Pharmaceuticals, Inc. Compositions for modulating expression of C9ORF72 antisense transcript
CA2985458A1 (en) 2015-05-09 2016-11-17 Two Blades Foundation Late blight resistance gene from solanum americanum and methods of use
CA2988415A1 (en) 2015-06-04 2016-12-08 Basf Se Recombinant microorganism for improved production of fine chemicals
US10837034B2 (en) 2015-06-12 2020-11-17 Basf Se Recombinant microorganism for improved production of alanine
EP3314250A4 (en) 2015-06-26 2018-12-05 Beth Israel Deaconess Medical Center, Inc. Cancer therapy targeting tetraspanin 33 (tspan33) in myeloid derived suppressor cells
AU2016287499B2 (en) 2015-06-29 2022-08-04 Caris Science, Inc. Therapeutic oligonucleotides
CA2993652A1 (en) 2015-07-28 2017-02-02 Caris Science, Inc. Targeted oligonucleotides
US10533175B2 (en) 2015-09-25 2020-01-14 Ionis Pharmaceuticals, Inc. Compositions and methods for modulating Ataxin 3 expression
WO2017062790A1 (en) 2015-10-09 2017-04-13 Two Blades Foundation Cold shock protein receptors and methods of use
WO2017066497A2 (en) 2015-10-13 2017-04-20 Duke University Genome engineering with type i crispr systems in eukaryotic cells
US20180312864A1 (en) 2015-10-22 2018-11-01 Basf Se Plants having increased tolerance to herbicides
AR106452A1 (es) 2015-10-22 2018-01-17 Basf Se Plantas que tienen una mayor tolerancia a herbicidas
WO2017075670A1 (en) 2015-11-05 2017-05-11 Children's Hospital Los Angeles "mobilizing leukemia cells"
WO2017087708A1 (en) 2015-11-19 2017-05-26 The Brigham And Women's Hospital, Inc. Lymphocyte antigen cd5-like (cd5l)-interleukin 12b (p40) heterodimers in immunity
CA3001623A1 (en) 2015-11-30 2017-06-08 Duke University Therapeutic targets for the correction of the human dystrophin gene by gene editing and methods of use
EP3389670A4 (en) 2015-12-04 2020-01-08 Ionis Pharmaceuticals, Inc. METHODS OF TREATING BREAST CANCER
WO2017099579A1 (en) 2015-12-07 2017-06-15 Erasmus University Medical Center Rotterdam Enzymatic replacement therapy and antisense therapy for pompe disease
EP3397288A4 (en) 2015-12-31 2019-09-11 Ionis Pharmaceuticals, Inc. PROCESS FOR REDUCING ATAXIN-2 EXPRESSION
AU2017205462A1 (en) 2016-01-05 2018-06-07 Ionis Pharmaceuticals, Inc. Methods for reducing LRRK2 expression
AU2017213826A1 (en) 2016-02-04 2018-08-23 Curis, Inc. Mutant smoothened and methods of using the same
CA3014036A1 (en) 2016-02-09 2017-08-17 Cibus Us Llc Methods and compositions for increasing efficiency of targeted gene modification using oligonucleotide-mediated gene repair
EP4512904A2 (en) 2016-02-25 2025-02-26 The Brigham and Women's Hospital, Inc. Treatment methods for fibrosis targeting smoc2
CN117089525A (zh) 2016-03-11 2023-11-21 奥驰亚客户服务有限公司 用于生产烟杈减少或消除的烟草植物和制品的组合物和方法
WO2017161168A1 (en) 2016-03-16 2017-09-21 Ionis Pharmaceuticals, Inc. Modulation of dyrk1b expression
CA3013799A1 (en) 2016-03-16 2017-09-21 Ionis Pharmaceuticals, Inc. Methods of modulating keap1
CN109715802A (zh) 2016-03-18 2019-05-03 卡里斯科学公司 寡核苷酸探针及其用途
WO2017167623A1 (en) 2016-03-30 2017-10-05 Basf Se Fermentative production of n-butylacrylate using alcohol acyl transferase enzymes
WO2017184500A1 (en) 2016-04-18 2017-10-26 Bloomsburg University of Pennsylvania Compositions and methods of delivering molecules to plants
US11608499B2 (en) 2016-04-29 2023-03-21 Basf Plant Science Company Gmbh Methods for modification of target nucleic acids
EP3054014A3 (en) 2016-05-10 2016-11-23 BASF Plant Science Company GmbH Use of a fungicide on transgenic plants
CA3024770A1 (en) 2016-05-20 2017-11-23 BASF Agro B.V. Dual transit peptides for targeting polypeptides
CA3025047A1 (en) 2016-05-24 2017-11-30 Basf Se Method for controlling ppo resistant weeds
EP3464597B1 (en) 2016-05-25 2022-08-03 Caris Science, Inc. Oligonucleotide probe selection method and uses thereof
HRP20241072T1 (hr) 2016-05-26 2024-11-08 Nunhems B.V. Biljke koje proizvode plod bez sjemena
US11236339B2 (en) 2016-06-17 2022-02-01 Ionis Pharmaceuticals, Inc. Modulation of GYS1 expression
JP2019524074A (ja) 2016-06-22 2019-09-05 ノース カロライナ ステート ユニバーシティＮｏｒｔｈ Ｃａｒｏｌｉｎａ Ｓｔａｔｅ Ｕｎｉｖｅｒｓｉｔｙ 植物における窒素の使用効率及び／又は窒素利用効率を増加させる方法
CA3030701A1 (en) 2016-07-11 2018-01-18 Translate Bio Ma, Inc. Nucleic acid conjugates and uses thereof
WO2018011750A1 (en) 2016-07-15 2018-01-18 Basf Se Plants having increased tolerance to herbicides
EP3487523B1 (en) 2016-07-19 2023-09-06 Duke University Therapeutic applications of cpf1-based genome editing
BR112019001483A2 (pt) 2016-07-27 2019-09-10 Basf Agro Bv método para controlar a vegetação indesejada em um local de cultivo de plantas
WO2018019845A1 (en) 2016-07-29 2018-02-01 Basf Se Method for controlling ppo resistant weeds
CA3030354A1 (en) 2016-07-29 2018-02-01 Basf Se Method for controlling ppo resistant weeds
US20210352900A1 (en) 2016-08-05 2021-11-18 Basf Se Method for Controlling PPO Resistant Weeds
NL2017294B1 (en) 2016-08-05 2018-02-14 Univ Erasmus Med Ct Rotterdam Natural cryptic exon removal by pairs of antisense oligonucleotides.
WO2018024696A1 (en) 2016-08-05 2018-02-08 Basf Se Method for controlling ppo resistant weeds
EP3278667A1 (en) 2016-08-05 2018-02-07 Basf Se Method for controlling ppo-inhibitor resistant weeds
NL2017295B1 (en) 2016-08-05 2018-02-14 Univ Erasmus Med Ct Rotterdam Antisense oligomeric compound for Pompe disease
WO2018029031A1 (en) 2016-08-09 2018-02-15 Basf Se Method for controlling ppo resistant weeds
EP3281524A1 (en) 2016-08-09 2018-02-14 Basf Se Method for controlling ppo resistant weeds
EP3281525A1 (en) 2016-08-09 2018-02-14 Basf Se Method for controlling ppo resistant weeds
CA3032223A1 (en) 2016-08-09 2018-02-15 Basf Se Method for controlling ppo resistant weeds
WO2018029034A1 (en) 2016-08-09 2018-02-15 Vib Vzw Cellulose synthase inhibitors and mutant plants
EP3281523A1 (en) 2016-08-09 2018-02-14 Basf Se Method for controlling ppo resistant weeds
US11723365B2 (en) 2016-08-09 2023-08-15 Basf Se Method for controlling PPO resistant weeds
WO2018067900A1 (en) 2016-10-06 2018-04-12 Ionis Pharmaceuticals, Inc. Method of conjugating oligomeric compounds
WO2018067985A1 (en) 2016-10-07 2018-04-12 Altria Client Services Llc Composition and methods for producing tobacco plants and products having reduced tobacco-specific nitrosamines (tsnas)
CA3037046A1 (en) 2016-10-31 2018-05-03 University Of Massachusetts Targeting microrna-101-3p in cancer therapy
JOP20190104A1 (ar) 2016-11-10 2019-05-07 Ionis Pharmaceuticals Inc مركبات وطرق لتقليل التعبير عن atxn3
EP3548620A4 (en) 2016-12-02 2020-07-22 Cold Spring Harbor Laboratory MODULATION OF THE EXPRESSION OF LNC05
CA3047121A1 (en) 2016-12-16 2018-06-21 Two Blades Foundation Late blight resistance genes and methods of use
WO2018114759A1 (en) 2016-12-20 2018-06-28 BASF Agro B.V. Plants having increased tolerance to herbicides
CN110114469A (zh) 2016-12-27 2019-08-09 因比奥斯公司 唾液酸化化合物的体内合成
WO2018140214A1 (en) 2017-01-24 2018-08-02 Pioneer Hi-Bred International, Inc. Nematicidal protein from pseudomonas
WO2018146481A1 (en) 2017-02-09 2018-08-16 Fujian Agriculture And Forestry University Expression of a phosphate transporter for improving plant yield
WO2018165564A1 (en) 2017-03-09 2018-09-13 Ionis Pharmaceuticals, Inc. Morpholino modified oligomeric compounds
ES2994451T3 (en) 2017-04-20 2025-01-24 Atyr Pharma Inc Compositions for treating lung inflammation
EP3612232A1 (en) 2017-04-21 2020-02-26 The Broad Institute, Inc. Targeted delivery to beta cells
US11445692B2 (en) 2017-05-15 2022-09-20 Equi-Nom Ltd. Quantitative trait loci (QTL) associated with shatter resistant capsules in sesame and uses thereof
EP3658675A1 (en) 2017-07-28 2020-06-03 Two Blades Foundation Potyvirus resistance genes and methods of use
AU2018318231A1 (en) 2017-08-18 2020-02-13 Ionis Pharmaceuticals, Inc. Modulation of the notch signaling pathway for treatment of respiratory disorders
WO2019051173A1 (en) 2017-09-08 2019-03-14 Ionis Pharmaceuticals, Inc. MODULATORS OF SMAD7 EXPRESSION
CN111108205B (zh) 2017-09-11 2024-05-28 奥驰亚客户服务有限公司 用于生产烟杈减少或消除的烟草植物和制品的组合物和方法
US11999953B2 (en) 2017-09-13 2024-06-04 The Children's Medical Center Corporation Compositions and methods for treating transposon associated diseases
TWI809004B (zh) 2017-11-09 2023-07-21 美商Ionis製藥公司 用於降低snca表現之化合物及方法
WO2019108619A1 (en) 2017-11-28 2019-06-06 Two Blades Foundation Methods and compositions for enhancing the disease resistance of plants
PH12020550693B1 (en) 2017-11-29 2024-04-17 Basf Se Plants having increased tolerance to herbicides
WO2019125804A1 (en) 2017-12-20 2019-06-27 Basf Se Nucleases and methods for making and using them
WO2019126641A2 (en) 2017-12-21 2019-06-27 Ionis Pharmaceuticals, Inc. Modulation of frataxin expression
US11034969B2 (en) 2017-12-22 2021-06-15 Altria Client Services Llc Plant comprising recombinant polynucleotides encoding a pigment regulatory transcription factor with a tissue-preferred promoter
CN107868123B (zh) 2017-12-25 2020-05-12 中国农业科学院作物科学研究所 一种同时提高植物产量和抗性的基因及其应用
CN118834883A (zh) 2018-01-09 2024-10-25 希博斯美国有限公司 防碎基因和突变
WO2019140102A1 (en) 2018-01-10 2019-07-18 Translate Bio Ma, Inc. Compositions and methods for facilitating delivery of synthetic nucleic acids to cells
WO2019140351A1 (en) 2018-01-12 2019-07-18 Two Blades Foundation Stem rust resistance genes and methods of use
PE20211242A1 (es) 2018-01-15 2021-07-09 Ionis Pharmaceuticals Inc Moduladores de la expresion dnm2
CN111601893A (zh) 2018-01-17 2020-08-28 巴斯夫欧洲公司 具有增加的除草剂耐受性的植物
WO2019158911A1 (en) 2018-02-14 2019-08-22 Institute Of Genetics And Developmental Biology Chinese Academy Of Sciences Methods of increasing nutrient use efficiency
EP3759127A4 (en) 2018-03-02 2022-03-30 Ionis Pharmaceuticals, Inc. COMPOUNDS AND METHODS FOR MODULATING AMYLOID BETA PRECURSOR PROTEIN
TWI840345B (zh) 2018-03-02 2024-05-01 美商Ionis製藥公司 Irf4表現之調節劑
US11661601B2 (en) 2018-03-22 2023-05-30 Ionis Pharmaceuticals, Inc. Methods for modulating FMR1 expression
EP4051799A2 (en) 2018-03-30 2022-09-07 Rheinische Friedrich-Wilhelms-Universität Bonn Aptamers for targeted activaton of t cell-mediated immunity
EP4062774B1 (en) 2018-04-03 2024-03-20 Altria Client Services LLC Composition and methods for producing tobacco plants and products having increased phenylalanine and reduced tobacco-specific nitrosamines (tsnas)
WO2019195738A1 (en) 2018-04-06 2019-10-10 Children's Medical Center Corporation Compositions and methods for somatic cell reprogramming and modulating imprinting
BR112020018698A2 (pt) 2018-04-11 2021-01-05 Ionis Pharmaceuticals, Inc. Moduladores de expressão de ezh2
CN112368375A (zh) 2018-04-26 2021-02-12 巴斯夫欧洲公司 脂肪酶
EP3788145A1 (en) 2018-05-03 2021-03-10 Basf Se Amylase enzymes
JOP20200280A1 (ar) 2018-05-09 2020-11-05 Ionis Pharmaceuticals Inc مركبات وطرق لتقليل التعبير الوراثي عن fxi
TW202003541A (zh) 2018-05-09 2020-01-16 美商Ionis製藥公司 用於減少ａｔｘｎ３表現之化合物及方法
WO2019219933A1 (en) 2018-05-17 2019-11-21 Vib Vzw An engineered combinatorial module of transcription factors to boost production of monoterpenoid indole alkaloids
US11833168B2 (en) 2018-06-14 2023-12-05 Ionis Pharmaceuticals, Inc. Compounds and methods for increasing STMN2 expression
WO2019238832A1 (en) 2018-06-15 2019-12-19 Nunhems B.V. Seedless watermelon plants comprising modifications in an abc transporter gene
TWI833770B (zh) 2018-06-27 2024-03-01 美商Ionis製藥公司 用於減少 lrrk2 表現之化合物及方法
CA3105394A1 (en) 2018-07-02 2020-01-09 Aptamir Therapeutics, Inc. Targeted delivery of therapeutic agents to human adipocytes
WO2020023737A1 (en) 2018-07-25 2020-01-30 Ionis Pharmaceuticals, Inc. Compounds and methods for reducing atxn2 expression
CA3110661A1 (en) 2018-08-29 2020-03-05 University Of Massachusetts Inhibition of protein kinases to treat friedreich ataxia
US20220025391A1 (en) 2018-09-07 2022-01-27 Basf Plant Science Company Gmbh Improved method for the production of high levels of pufa in plants
CN113412332A (zh) 2018-09-07 2021-09-17 巴斯夫植物科学有限公司 用于在植物中产生高水平pufa的改进方法
AU2019336533A1 (en) 2018-09-07 2021-03-25 Basf Plant Science Company Gmbh Improved method for the production of high levels of PUFA in plants
CN113195727A (zh) 2018-10-18 2021-07-30 巴斯夫欧洲公司 用于产生丙烯酸或其盐的方法
TW202028222A (zh) 2018-11-14 2020-08-01 美商Ionis製藥公司 Foxp3表現之調節劑
US11208650B2 (en) 2018-11-15 2021-12-28 Ionis Pharmaceuticals, Inc. Modulators of IRF5 expression
CA3124395A1 (en) 2018-12-20 2020-06-25 Basf Plant Science Company Gmbh Native delivery of biomolecules into plant cells using ionic complexes with cell-penetrating peptides
EP3914725A2 (en) 2019-01-22 2021-12-01 Basf Se Method for production of 4-cyano benzoic acid or salts thereof
CN113660857A (zh) 2019-01-24 2021-11-16 奥驰亚客户服务有限公司 包含降低的烟碱和降低的烟草特异性亚硝胺的烟草植物
US11214803B2 (en) 2019-01-31 2022-01-04 Ionis Pharmaceuticals, Inc. Modulators of YAP1 expression
WO2020171889A1 (en) 2019-02-19 2020-08-27 University Of Rochester Blocking lipid accumulation or inflammation in thyroid eye disease
GB201902253D0 (en) 2019-02-19 2019-04-03 Univ Court Univ Of Glasgow Methods for optogenetic manipulation of stomatal function
MX2021010152A (es) 2019-02-27 2021-09-14 Ionis Pharmaceuticals Inc Moduladores de la expresion de malat1.
WO2020185737A1 (en) 2019-03-11 2020-09-17 Basf Se Amylases and methods for making and using them
WO2020183191A1 (en) 2019-03-14 2020-09-17 Rothamsted Research Limited Genetically modified plants with enhanced drought tolerance
WO2020193532A1 (en) 2019-03-25 2020-10-01 Basf Se Cleaning composition having amylase enzymes
EP3947665A2 (en) 2019-03-25 2022-02-09 Basf Se Amylase enzymes
EP3947664A2 (en) 2019-03-25 2022-02-09 Basf Se Amylase enzymes
SG11202110679YA (en) 2019-03-29 2021-10-28 Ionis Pharmaceuticals Inc Compounds and methods for modulating ube3a-ats
AU2020274594A1 (en) 2019-05-10 2022-01-20 Basf Se Regulatory nucleic acid molecules for enhancing gene expression in plants
KR20220029579A (ko) 2019-06-27 2022-03-08 바스프 플랜트 사이언스 컴퍼니 게엠베하 진균 포자의 형질전환 방법
BR112021026248A2 (pt) 2019-06-27 2022-03-03 Two Blades Found Molécula de ácido nucleico isolada que codifica uma proteína atrlp23 engenheirada, proteína atrlp23 engenheirada, cassete de expressão, vetor, célula hospedeira, planta ou célula vegetal, métodos para fazer uma proteína atrlp23 engenheirada, para fazer uma molécula de ácido nucleico que codifica uma proteína atrlp23 engenheirada e para intensificar a resistência de uma planta
US20210071193A1 (en) 2019-07-12 2021-03-11 The Regents Of The University Of California Plants with enhanced resistance to bacterial pathogens
EP3956450A4 (en) 2019-07-26 2022-11-16 Ionis Pharmaceuticals, Inc. Compounds and methods for modulating gfap
EP4013767A4 (en) 2019-08-15 2023-10-25 Ionis Pharmaceuticals, Inc. COMPOUND-MODIFIED OLIGOMERIC COMPOUNDS AND USES THEREOF
WO2021032881A1 (en) 2019-08-22 2021-02-25 Basf Se Amylase variants
AU2020344905A1 (en) 2019-09-12 2022-04-28 Basf Se Regulatory nucleic acid molecules for enhancing gene expression in plants
WO2021058691A1 (en) 2019-09-26 2021-04-01 Basf Se Method for the production of beta-alanine or salts thereof
WO2021069387A1 (en) 2019-10-07 2021-04-15 Basf Se Regulatory nucleic acid molecules for enhancing gene expression in plants
CA3159805A1 (en) 2019-12-03 2021-06-10 Frank Meulewaeter Regulatory nucleic acid molecules for enhancing gene expression in plants
CA3161392A1 (en) 2019-12-16 2021-06-24 David DE VLEESSCHAUWER Codon-optimized cas9 endonuclease encoding polynucleotide
US20230220405A1 (en) 2019-12-16 2023-07-13 BASF Agricultural Solutions Seed US LLC Precise introduction of dna or mutations into the genome of wheat
CA3161254A1 (en) 2019-12-16 2021-06-24 Katelijn D'HALLUIN Improved genome editing using paired nickases
JOP20220201A1 (ar) 2020-02-28 2023-01-30 Ionis Pharmaceuticals Inc مركبات وطرق لتعديل smn2
EP4114954A1 (en) 2020-03-04 2023-01-11 Basf Se Method for the production of constitutive bacterial promoters conferring low to medium expression
EP4114956A1 (en) 2020-03-04 2023-01-11 Basf Se Shuttle vector for expression in e. coli and bacilli
MX2022013707A (es) 2020-05-01 2022-12-07 Ionis Pharmaceuticals Inc Compuestos y metodos para modular atxn1.
CN115605589A (zh) 2020-05-15 2023-01-13 巴斯夫欧洲公司（De） 改进的用于生产类异戊二烯的方法
TW202216996A (zh) 2020-06-29 2022-05-01 美商Ionis製藥公司 調節ｐｌｐ１之化合物及方法
PE20231567A1 (es) 2020-08-07 2023-10-04 Ionis Pharmaceuticals Inc Compuestos y metodos para modular el scn2a
US11730133B2 (en) 2020-10-21 2023-08-22 Equi-Nom Ltd High yield sesame
IL302817A (en) 2020-11-18 2023-07-01 Ionis Pharmaceuticals Inc Compounds and methods for modulating angiotensinogen expression
IL303800A (en) 2020-12-18 2023-08-01 Ionis Pharmaceuticals Inc Compounds and methods for modulating factor xii
EP4336997A1 (en) 2021-05-11 2024-03-20 Two Blades Foundation Methods for preparing a library of plant disease resistance genes for functional testing for disease resistance
TW202317765A (zh) 2021-06-18 2023-05-01 美商Ionis製藥公司 用於降低ｉｆｎａｒ１表現的化合物及方法
CN118019447A (zh) 2021-08-06 2024-05-10 Kws蔬菜有限责任公司 菠菜对霜霉病的持久抗性
WO2023031161A1 (en) 2021-09-03 2023-03-09 BASF Agricultural Solutions Seed US LLC Plants having increased tolerance to herbicides
US11395470B1 (en) 2021-09-14 2022-07-26 Equi-Nom Ltd. Sesame with high oil content and/or high yield
US20240376473A1 (en) 2021-09-16 2024-11-14 Qmine Co., Ltd. Antisense compound for modulating wfdc2 expression
US20250002929A1 (en) 2021-09-30 2025-01-02 The Sainsbury Laboratory Plant disease resistance genes against stem rust and methods of use
WO2023067192A1 (en) 2021-10-21 2023-04-27 Consejo Superior De Investigaciones Cientificas (Csic) Methods for improving abiotic stress resistance
US20250064032A1 (en) 2021-12-10 2025-02-27 Pig Improvement Company Uk Limited Editing tmprss2/4 for disease resistance in livestock
CA3240580A1 (en) 2021-12-22 2023-06-29 Timothy James Golds Improved screening method for genome edited events
WO2023131616A1 (en) 2022-01-05 2023-07-13 Vib Vzw Means and methods to increase abiotic stress tolerance in plants
WO2023131637A1 (en) 2022-01-06 2023-07-13 Vib Vzw Improved silage grasses
WO2023144199A1 (en) 2022-01-26 2023-08-03 Vib Vzw Plants having reduced levels of bitter taste metabolites
WO2024026474A1 (en) 2022-07-29 2024-02-01 Regeneron Pharmaceuticals, Inc. Compositions and methods for transferrin receptor (tfr)-mediated delivery to the brain and muscle
WO2024044352A1 (en) 2022-08-26 2024-02-29 The General Hospital Corporation Methods and compositions for prognosis and treatment of dilated cardiomyopathy and heart failure
US12152052B2 (en) 2022-09-23 2024-11-26 Ionis Pharmaceuticals, Inc. Compounds and methods for reducing MECP2 expression
WO2024083579A1 (en) 2022-10-20 2024-04-25 Basf Se Regulatory nucleic acid molecules for enhancing gene expression in plants
WO2024089011A1 (en) 2022-10-26 2024-05-02 BASF Agricultural Solutions Seed US LLC Excision of recombinant dna from the genome of plant cells
WO2024094678A2 (en) 2022-11-02 2024-05-10 Basf Se Improved method for the production of natural vanillin
WO2024098002A1 (en) 2022-11-04 2024-05-10 Regeneron Pharmaceuticals, Inc. Calcium voltage-gated channel auxiliary subunit gamma 1 (cacng1) binding proteins and cacng1-mediated delivery to skeletal muscle
WO2024107765A2 (en) 2022-11-14 2024-05-23 Regeneron Pharmaceuticals, Inc. Compositions and methods for fibroblast growth factor receptor 3-mediated delivery to astrocytes
WO2024126113A1 (en) 2022-12-12 2024-06-20 BASF Agricultural Solutions Seed US LLC Plants having increased tolerance to herbicides
WO2024132947A1 (en) 2022-12-19 2024-06-27 Basf Se New cellulase promoters for fungal protein production
WO2024156593A1 (en) 2023-01-27 2024-08-02 Basf Se New genomic integration site for fungal protein and fine chemicals production
WO2024240748A1 (en) 2023-05-22 2024-11-28 Basf Se Improved method for the formation of amides
WO2025019283A1 (en) 2023-07-14 2025-01-23 Two Blades Foundation Methods of improving the thermostability of plant immune receptors
WO2025019221A1 (en) 2023-07-15 2025-01-23 Two Blades Foundation Broad-spectrum polerovirus resistance gene

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4503151A (en) * 1980-12-10 1985-03-05 Research Corporation Recombinant cDNA construction method and hybrid nucleotides useful in cloning
US4873191A (en) * 1981-06-12 1989-10-10 Ohio University Genetic transformation of zygotes
US4882279A (en) * 1985-10-25 1989-11-21 Phillips Petroleum Company Site selective genomic modification of yeast of the genus pichia
EP0260032B1 (en) * 1986-09-08 1994-01-26 Ajinomoto Co., Inc. Compounds for the cleavage at a specific position of RNA, oligomers employed for the formation of said compounds, and starting materials for the synthesis of said oligomers
US4950599A (en) * 1987-01-29 1990-08-21 Wolf Bertling Method for exchanging homologous DNA sequences in a cell using polyoma encapsulated DNA fragments
WO1990014092A1 (en) * 1989-05-18 1990-11-29 Cell Genesys, Inc. Single-strand site-directed modification of mammalian genes in vivo
EP0626012B1 (en) * 1992-02-11 2003-07-09 Cell Genesys, Inc. Homogenotization of gene-targeting events
AU4115693A (en) * 1992-04-24 1993-11-29 Sri International In vivo homologous sequence targeting in eukaryotic cells
WO1994004032A1 (en) * 1992-08-21 1994-03-03 The Regents Of The University Of California Composition and method for altering dna sequences by homologous recombination
JPH08510900A (ja) * 1993-03-31 1996-11-19 ハイブライドン インコーポレイテッド 改良された抗インフルエンザ活性を有する修飾オリゴヌクレオチド

Also Published As

Publication number Publication date
DE69425903D1 (de) 2000-10-19
US5871984A (en) 1999-02-16
NZ278490A (en) 1998-03-25
CN1117866C (zh) 2003-08-13
DK0733059T3 (da) 2000-10-16
WO1995015972A1 (en) 1995-06-15
EP0733059A4 (en) 1997-05-21
AU691550B2 (en) 1998-05-21
CA2178729A1 (en) 1995-06-15
AU1399595A (en) 1995-06-27
EP0733059A1 (en) 1996-09-25
PT733059E (pt) 2001-03-30
GR3034988T3 (en) 2001-03-30
ES2149962T3 (es) 2000-11-16
DE733059T1 (de) 1997-08-28
JP3585238B2 (ja) 2004-11-04
JPH09506511A (ja) 1997-06-30
KR960706500A (ko) 1996-12-09
CN1048254C (zh) 2000-01-12
KR100386337B1 (ko) 2004-03-24
DE69425903T2 (de) 2001-02-15
CN1142829A (zh) 1997-02-12
US5565350A (en) 1996-10-15
US5756325A (en) 1998-05-26
EP0733059B1 (en) 2000-09-13
ATE196311T1 (de) 2000-09-15

Similar Documents

Publication Publication Date Title
CN1215755A (zh) 将预定改变引入有核细胞基因组的靶序列中的方法
JP6888213B2 (ja) 簡便で高効率の遺伝子改変非ヒト哺乳動物の作製方法
CN1309717A (zh) 无细胞嵌合体制备技术和异源双螺旋突变载体的真核应用
CN110551759B (zh) 一种提高转基因细胞重组效率的组合物及方法
WO2010085699A2 (en) Mammalian piggybac transposon and methods of use
Weaver et al. Genome plasticity in Streptomyces: identification of 1 Mb TIRs in the S. coelicolor A3 (2) chromosome
CN103168101A (zh) 使用靶向核酸内切酶和单链核酸的基因组编辑
JP2022002519A (ja) ゲノム編集方法
CN1175281A (zh) 立体特异性硫代磷酸寡核苷酸的合成
JP2019536462A (ja) 内因性および起源ＤＮＡのワンショットガイドＲＮＡ（ｏｇＲＮＡ）標的化のためのシステムおよび方法
CN1387576A (zh) 真核细胞中序列特异性dna重组
JPWO2018030208A1 (ja) 遺伝子ノックイン細胞の作製方法
CN106086031A (zh) 猪肌抑素基因编辑位点及其应用
CN106754949B (zh) 猪肌抑素基因编辑位点864-883及其应用
CN1262668C (zh) 转移核酸通过核被膜的细胞转运系统的用途
Matsuoka et al. Germline transgenesis of the ascidian Ciona intestinalis by electroporation
EP1869193B1 (en) Reconstructed human mariner transposon capable of stable gene transfer into chromosomes in vertebrates
CN1620503A (zh) 细胞内制备单链dna
Awazu et al. High‐throughput enhancer trap by remobilization of transposon Minos in Ciona intestinalis
Hermanson et al. Sleeping Beauty transposon for efficient gene delivery
CN1230540C (zh) 果蝇重组相关蛋白质及其使用方法
US7883890B2 (en) Transposon transfer factor functioned in mammal
CN108715862A (zh) ddx19基因缺失斑马鱼突变体的制备方法
CN1292827A (zh) 核酸转移载体、含有它们的组合物及其应用
CN115703842A (zh) 高效率高精度的胞嘧啶c到鸟嘌呤g转变的碱基编辑器

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee